{"text":"The p.A467T mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.A467T as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.A467T was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.A467T may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.A467T is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.A467T was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.A467T is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.A467T was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.A467T is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.A467T in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.W748S mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.W748S as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.W748S was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.W748S may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.W748S is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.W748S was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.W748S is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.W748S was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.W748S is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.W748S in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.T251I mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.T251I as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.T251I was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.T251I may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.T251I is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.T251I was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.T251I is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.T251I was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.T251I is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.T251I in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.P587L mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.P587L as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.P587L was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.P587L may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.P587L is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.P587L was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.P587L is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.P587L was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.P587L is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.P587L in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.G848S mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.G848S as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.G848S was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.G848S may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.G848S is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.G848S was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.G848S is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.G848S was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.G848S is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.G848S in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The missense mutation p.M430L is known to disrupt mitochondrial function.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Studies have linked the variant p.M430L to severe neuromuscular symptoms.","spans":[{"start":32,"end":39,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing revealed the pathogenic substitution p.M430L.","spans":[{"start":53,"end":60,"label":"GENE_VARIANT"}]}
{"text":"p.M430L alters a conserved residue critical for protein stability.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patients harboring p.M430L often present with early-onset phenotypes.","spans":[{"start":19,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"The p.M430L mutation compromises the DNA polymerase gamma enzyme.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"p.M430L has been implicated in multiple mitochondrial pathologies.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Researchers observed that p.M430L causes loss-of-function effects.","spans":[{"start":25,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.M430L is associated with progressive neurological decline.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Functional assays demonstrate that p.M430L impairs enzymatic activity.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.W918R is known to disrupt mitochondrial function.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Studies have linked the variant p.W918R to severe neuromuscular symptoms.","spans":[{"start":32,"end":39,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing revealed the pathogenic substitution p.W918R.","spans":[{"start":53,"end":60,"label":"GENE_VARIANT"}]}
{"text":"p.W918R alters a conserved residue critical for protein stability.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patients harboring p.W918R often present with early-onset phenotypes.","spans":[{"start":19,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"The p.W918R mutation compromises the DNA polymerase gamma enzyme.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"p.W918R has been implicated in multiple mitochondrial pathologies.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Researchers observed that p.W918R causes loss-of-function effects.","spans":[{"start":25,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.W918R is associated with progressive neurological decline.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Functional assays demonstrate that p.W918R impairs enzymatic activity.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.A862T is known to disrupt mitochondrial function.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Studies have linked the variant p.A862T to severe neuromuscular symptoms.","spans":[{"start":32,"end":39,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing revealed the pathogenic substitution p.A862T.","spans":[{"start":53,"end":60,"label":"GENE_VARIANT"}]}
{"text":"p.A862T alters a conserved residue critical for protein stability.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patients harboring p.A862T often present with early-onset phenotypes.","spans":[{"start":19,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"The p.A862T mutation compromises the DNA polymerase gamma enzyme.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"p.A862T has been implicated in multiple mitochondrial pathologies.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Researchers observed that p.A862T causes loss-of-function effects.","spans":[{"start":25,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.A862T is associated with progressive neurological decline.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Functional assays demonstrate that p.A862T impairs enzymatic activity.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.H277L is known to disrupt mitochondrial function.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Studies have linked the variant p.H277L to severe neuromuscular symptoms.","spans":[{"start":32,"end":39,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing revealed the pathogenic substitution p.H277L.","spans":[{"start":53,"end":60,"label":"GENE_VARIANT"}]}
{"text":"p.H277L alters a conserved residue critical for protein stability.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patients harboring p.H277L often present with early-onset phenotypes.","spans":[{"start":19,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"The p.H277L mutation compromises the DNA polymerase gamma enzyme.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"p.H277L has been implicated in multiple mitochondrial pathologies.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Researchers observed that p.H277L causes loss-of-function effects.","spans":[{"start":25,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.H277L is associated with progressive neurological decline.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Functional assays demonstrate that p.H277L impairs enzymatic activity.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.Arg1096Cys is known to disrupt mitochondrial function.","spans":[{"start":22,"end":35,"label":"GENE_VARIANT"}]}
{"text":"Studies have linked the variant p.Arg1096Cys to severe neuromuscular symptoms.","spans":[{"start":32,"end":45,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing revealed the pathogenic substitution p.Arg1096Cys.","spans":[{"start":53,"end":66,"label":"GENE_VARIANT"}]}
{"text":"p.Arg1096Cys alters a conserved residue critical for protein stability.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Patients harboring p.Arg1096Cys often present with early-onset phenotypes.","spans":[{"start":19,"end":32,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"The p.Arg1096Cys mutation compromises the DNA polymerase gamma enzyme.","spans":[{"start":4,"end":17,"label":"GENE_VARIANT"}]}
{"text":"p.Arg1096Cys has been implicated in multiple mitochondrial pathologies.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Researchers observed that p.Arg1096Cys causes loss-of-function effects.","spans":[{"start":25,"end":38,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.Arg1096Cys is associated with progressive neurological decline.","spans":[{"start":11,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Functional assays demonstrate that p.Arg1096Cys impairs enzymatic activity.","spans":[{"start":33,"end":46,"label":"GENE_VARIANT"}]}
{"text":"p.M430L was found in the patient and is known to impair mitochondrial replication.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":25,"end":32,"label":"PATIENT"}]}
{"text":"The variant p.M430L has been linked to neurodegenerative progression in affected individuals.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Pathogenicity of p.M430L was confirmed in a child presenting early symptoms.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":42,"end":47,"label":"PATIENT"}]}
{"text":"Mutations such as p.M430L were identified during follow-up evaluations.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":44,"end":53,"label":"AGE_FOLLOWUP"}]}
{"text":"In cases where p.M430L was present, the patient often died at 5 years.","spans":[{"start":15,"end":22,"label":"GENE_VARIANT"},{"start":39,"end":46,"label":"PATIENT"},{"start":53,"end":63,"label":"AGE_DEATH"}]}
{"text":"Emergence of p.M430L in clinical sequencing suggested mitochondrial disease.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The child carrying p.M430L exhibited motor regression and cognitive decline.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"Follow-up revealed p.M430L as a likely cause of progressive symptoms.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"AGE_FOLLOWUP"}]}
{"text":"With p.M430L detected, patients showed a rapid clinical deterioration.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"},{"start":23,"end":31,"label":"PATIENT"}]}
{"text":"p.M430L mutation appears in mitochondrial disorders with early onset in children.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":61,"end":69,"label":"PATIENT"}]}
{"text":"p.W918R was found in the patient and is known to impair mitochondrial replication.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":25,"end":32,"label":"PATIENT"}]}
{"text":"The variant p.W918R has been linked to neurodegenerative progression in affected individuals.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Pathogenicity of p.W918R was confirmed in a child presenting early symptoms.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":42,"end":47,"label":"PATIENT"}]}
{"text":"Mutations such as p.W918R were identified during follow-up evaluations.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":44,"end":53,"label":"AGE_FOLLOWUP"}]}
{"text":"In cases where p.W918R was present, the patient often died at 5 years.","spans":[{"start":15,"end":22,"label":"GENE_VARIANT"},{"start":39,"end":46,"label":"PATIENT"},{"start":53,"end":63,"label":"AGE_DEATH"}]}
{"text":"Emergence of p.W918R in clinical sequencing suggested mitochondrial disease.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The child carrying p.W918R exhibited motor regression and cognitive decline.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"Follow-up revealed p.W918R as a likely cause of progressive symptoms.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"AGE_FOLLOWUP"}]}
{"text":"With p.W918R detected, patients showed a rapid clinical deterioration.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"},{"start":23,"end":31,"label":"PATIENT"}]}
{"text":"p.W918R mutation appears in mitochondrial disorders with early onset in children.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":61,"end":69,"label":"PATIENT"}]}
{"text":"p.A862T was found in the patient and is known to impair mitochondrial replication.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":25,"end":32,"label":"PATIENT"}]}
{"text":"The variant p.A862T has been linked to neurodegenerative progression in affected individuals.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Pathogenicity of p.A862T was confirmed in a child presenting early symptoms.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":42,"end":47,"label":"PATIENT"}]}
{"text":"Mutations such as p.A862T were identified during follow-up evaluations.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":44,"end":53,"label":"AGE_FOLLOWUP"}]}
{"text":"In cases where p.A862T was present, the patient often died at 5 years.","spans":[{"start":15,"end":22,"label":"GENE_VARIANT"},{"start":39,"end":46,"label":"PATIENT"},{"start":53,"end":63,"label":"AGE_DEATH"}]}
{"text":"Emergence of p.A862T in clinical sequencing suggested mitochondrial disease.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The child carrying p.A862T exhibited motor regression and cognitive decline.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"Follow-up revealed p.A862T as a likely cause of progressive symptoms.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"AGE_FOLLOWUP"}]}
{"text":"With p.A862T detected, patients showed a rapid clinical deterioration.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"},{"start":23,"end":31,"label":"PATIENT"}]}
{"text":"p.A862T mutation appears in mitochondrial disorders with early onset in children.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":61,"end":69,"label":"PATIENT"}]}
{"text":"p.H277L was found in the patient and is known to impair mitochondrial replication.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":25,"end":32,"label":"PATIENT"}]}
{"text":"The variant p.H277L has been linked to neurodegenerative progression in affected individuals.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Pathogenicity of p.H277L was confirmed in a child presenting early symptoms.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":42,"end":47,"label":"PATIENT"}]}
{"text":"Mutations such as p.H277L were identified during follow-up evaluations.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":44,"end":53,"label":"AGE_FOLLOWUP"}]}
{"text":"In cases where p.H277L was present, the patient often died at 5 years.","spans":[{"start":15,"end":22,"label":"GENE_VARIANT"},{"start":39,"end":46,"label":"PATIENT"},{"start":53,"end":63,"label":"AGE_DEATH"}]}
{"text":"Emergence of p.H277L in clinical sequencing suggested mitochondrial disease.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The child carrying p.H277L exhibited motor regression and cognitive decline.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"Follow-up revealed p.H277L as a likely cause of progressive symptoms.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"AGE_FOLLOWUP"}]}
{"text":"With p.H277L detected, patients showed a rapid clinical deterioration.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"},{"start":23,"end":31,"label":"PATIENT"}]}
{"text":"p.H277L mutation appears in mitochondrial disorders with early onset in children.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":61,"end":69,"label":"PATIENT"}]}
{"text":"p.Arg1096Cys was found in the patient and is known to impair mitochondrial replication.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"},{"start":31,"end":38,"label":"PATIENT"}]}
{"text":"The variant p.Arg1096Cys has been linked to neurodegenerative progression in affected individuals.","spans":[{"start":12,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Pathogenicity of p.Arg1096Cys was confirmed in a child presenting early symptoms.","spans":[{"start":17,"end":30,"label":"GENE_VARIANT"},{"start":48,"end":53,"label":"PATIENT"}]}
{"text":"Mutations such as p.Arg1096Cys were identified during follow-up evaluations.","spans":[{"start":18,"end":31,"label":"GENE_VARIANT"},{"start":50,"end":59,"label":"AGE_FOLLOWUP"}]}
{"text":"In cases where p.Arg1096Cys was present, the patient often died at 5 years.","spans":[{"start":15,"end":28,"label":"GENE_VARIANT"},{"start":45,"end":52,"label":"PATIENT"},{"start":59,"end":69,"label":"AGE_DEATH"}]}
{"text":"Emergence of p.Arg1096Cys in clinical sequencing suggested mitochondrial disease.","spans":[{"start":13,"end":26,"label":"GENE_VARIANT"}]}
{"text":"The child carrying p.Arg1096Cys exhibited motor regression and cognitive decline.","spans":[{"start":20,"end":33,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"Follow-up revealed p.Arg1096Cys as a likely cause of progressive symptoms.","spans":[{"start":18,"end":31,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"AGE_FOLLOWUP"}]}
{"text":"With p.Arg1096Cys detected, patients showed a rapid clinical deterioration.","spans":[{"start":5,"end":18,"label":"GENE_VARIANT"},{"start":36,"end":44,"label":"PATIENT"}]}
{"text":"p.Arg1096Cys mutation appears in mitochondrial disorders with early onset in children.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"},{"start":67,"end":75,"label":"PATIENT"}]}
{"text":"The patient was found to carry the variant p.K1191R, which affects mitochondrial polymerase activity.","spans":[{"start":43,"end":51,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A child presenting with muscle weakness was found to harbor p.K1191R.","spans":[{"start":60,"end":68,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed the mutation p.K1191R during follow-up testing in affected individuals.","spans":[{"start":33,"end":41,"label":"GENE_VARIANT"},{"start":49,"end":58,"label":"AGE_FOLLOWUP"}]}
{"text":"Clinical decline was observed in patients carrying the p.K1191R substitution.","spans":[{"start":47,"end":55,"label":"GENE_VARIANT"},{"start":33,"end":41,"label":"PATIENT"}]}
{"text":"Presence of p.K1191R in the patient correlated with early death at 5.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"},{"start":28,"end":35,"label":"PATIENT"},{"start":54,"end":65,"label":"AGE_DEATH"}]}
{"text":"p.K1191R was identified in a child diagnosed with mitochondrial encephalopathy.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":28,"end":33,"label":"PATIENT"}]}
{"text":"Patients with p.K1191R tend to show progressive motor symptoms and regression.","spans":[{"start":13,"end":21,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"Genetic analysis uncovered p.K1191R as a likely pathogenic mutation.","spans":[{"start":26,"end":34,"label":"GENE_VARIANT"}]}
{"text":"In follow-up visits, the variant p.K1191R consistently appeared in severe cases.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"},{"start":3,"end":12,"label":"AGE_FOLLOWUP"}]}
{"text":"Muscle biopsy in the patient revealed signs consistent with p.K1191R-related pathology.","spans":[{"start":50,"end":58,"label":"GENE_VARIANT"},{"start":21,"end":28,"label":"PATIENT"}]}
{"text":"The patient was found to carry the variant p.K1191R, which affects mitochondrial polymerase activity.","spans":[{"start":43,"end":51,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A child presenting with muscle weakness was found to harbor p.K1191R.","spans":[{"start":60,"end":68,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed the mutation p.K1191R during follow-up testing in affected individuals.","spans":[{"start":33,"end":41,"label":"GENE_VARIANT"},{"start":49,"end":58,"label":"AGE_FOLLOWUP"}]}
{"text":"Clinical decline was observed in patients carrying the p.K1191R substitution.","spans":[{"start":47,"end":55,"label":"GENE_VARIANT"},{"start":33,"end":41,"label":"PATIENT"}]}
{"text":"Presence of p.K1191R in the patient correlated with early death at 5.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"},{"start":28,"end":35,"label":"PATIENT"},{"start":54,"end":65,"label":"AGE_DEATH"}]}
{"text":"p.K1191R was identified in a child diagnosed with mitochondrial encephalopathy.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":28,"end":33,"label":"PATIENT"}]}
{"text":"Patients with p.K1191R tend to show progressive motor symptoms and regression.","spans":[{"start":13,"end":21,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"Genetic analysis uncovered p.K1191R as a likely pathogenic mutation.","spans":[{"start":26,"end":34,"label":"GENE_VARIANT"}]}
{"text":"In follow-up visits, the variant p.K1191R consistently appeared in severe cases.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"},{"start":3,"end":12,"label":"AGE_FOLLOWUP"}]}
{"text":"Muscle biopsy in the patient revealed signs consistent with p.K1191R-related pathology.","spans":[{"start":50,"end":58,"label":"GENE_VARIANT"},{"start":21,"end":28,"label":"PATIENT"}]}
{"text":"The patient was found to carry the variant p.R386C, which affects mitochondrial polymerase activity.","spans":[{"start":43,"end":50,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A child presenting with muscle weakness was found to harbor p.R386C.","spans":[{"start":60,"end":67,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed the mutation p.R386C during follow-up testing in affected individuals.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"},{"start":48,"end":57,"label":"AGE_FOLLOWUP"}]}
{"text":"Clinical decline was observed in patients carrying the p.R386C substitution.","spans":[{"start":47,"end":54,"label":"GENE_VARIANT"},{"start":33,"end":41,"label":"PATIENT"}]}
{"text":"Presence of p.R386C in the patient correlated with early death at 5.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"},{"start":27,"end":34,"label":"PATIENT"},{"start":53,"end":64,"label":"AGE_DEATH"}]}
{"text":"p.R386C was identified in a child diagnosed with mitochondrial encephalopathy.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":27,"end":32,"label":"PATIENT"}]}
{"text":"Patients with p.R386C tend to show progressive motor symptoms and regression.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"Genetic analysis uncovered p.R386C as a likely pathogenic mutation.","spans":[{"start":26,"end":33,"label":"GENE_VARIANT"}]}
{"text":"In follow-up visits, the variant p.R386C consistently appeared in severe cases.","spans":[{"start":29,"end":36,"label":"GENE_VARIANT"},{"start":3,"end":12,"label":"AGE_FOLLOWUP"}]}
{"text":"Muscle biopsy in the patient revealed signs consistent with p.R386C-related pathology.","spans":[{"start":50,"end":57,"label":"GENE_VARIANT"},{"start":21,"end":28,"label":"PATIENT"}]}
{"text":"The patient was found to carry the variant p.H932Y, which affects mitochondrial polymerase activity.","spans":[{"start":43,"end":50,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A child presenting with muscle weakness was found to harbor p.H932Y.","spans":[{"start":60,"end":67,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed the mutation p.H932Y during follow-up testing in affected individuals.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"},{"start":48,"end":57,"label":"AGE_FOLLOWUP"}]}
{"text":"Clinical decline was observed in patients carrying the p.H932Y substitution.","spans":[{"start":47,"end":54,"label":"GENE_VARIANT"},{"start":33,"end":41,"label":"PATIENT"}]}
{"text":"Presence of p.H932Y in the patient correlated with early death at 5.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"},{"start":27,"end":34,"label":"PATIENT"},{"start":53,"end":64,"label":"AGE_DEATH"}]}
{"text":"p.H932Y was identified in a child diagnosed with mitochondrial encephalopathy.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":27,"end":32,"label":"PATIENT"}]}
{"text":"Patients with p.H932Y tend to show progressive motor symptoms and regression.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"Genetic analysis uncovered p.H932Y as a likely pathogenic mutation.","spans":[{"start":26,"end":33,"label":"GENE_VARIANT"}]}
{"text":"In follow-up visits, the variant p.H932Y consistently appeared in severe cases.","spans":[{"start":29,"end":36,"label":"GENE_VARIANT"},{"start":3,"end":12,"label":"AGE_FOLLOWUP"}]}
{"text":"Muscle biopsy in the patient revealed signs consistent with p.H932Y-related pathology.","spans":[{"start":50,"end":57,"label":"GENE_VARIANT"},{"start":21,"end":28,"label":"PATIENT"}]}
{"text":"The patient was found to carry the variant p.Tyr955Cys, which affects mitochondrial polymerase activity.","spans":[{"start":43,"end":54,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A child presenting with muscle weakness was found to harbor p.Tyr955Cys.","spans":[{"start":60,"end":71,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed the mutation p.Tyr955Cys during follow-up testing in affected individuals.","spans":[{"start":33,"end":44,"label":"GENE_VARIANT"},{"start":52,"end":61,"label":"AGE_FOLLOWUP"}]}
{"text":"Clinical decline was observed in patients carrying the p.Tyr955Cys substitution.","spans":[{"start":47,"end":58,"label":"GENE_VARIANT"},{"start":33,"end":41,"label":"PATIENT"}]}
{"text":"Presence of p.Tyr955Cys in the patient correlated with early death at 5.","spans":[{"start":12,"end":23,"label":"GENE_VARIANT"},{"start":31,"end":38,"label":"PATIENT"},{"start":57,"end":68,"label":"AGE_DEATH"}]}
{"text":"p.Tyr955Cys was identified in a child diagnosed with mitochondrial encephalopathy.","spans":[{"start":0,"end":11,"label":"GENE_VARIANT"},{"start":31,"end":36,"label":"PATIENT"}]}
{"text":"Patients with p.Tyr955Cys tend to show progressive motor symptoms and regression.","spans":[{"start":13,"end":24,"label":"GENE_VARIANT"},{"start":0,"end":8,"label":"PATIENT"}]}
{"text":"Genetic analysis uncovered p.Tyr955Cys as a likely pathogenic mutation.","spans":[{"start":26,"end":37,"label":"GENE_VARIANT"}]}
{"text":"In follow-up visits, the variant p.Tyr955Cys consistently appeared in severe cases.","spans":[{"start":29,"end":40,"label":"GENE_VARIANT"},{"start":3,"end":12,"label":"AGE_FOLLOWUP"}]}
{"text":"Muscle biopsy in the patient revealed signs consistent with p.Tyr955Cys-related pathology.","spans":[{"start":50,"end":61,"label":"GENE_VARIANT"},{"start":21,"end":28,"label":"PATIENT"}]}
{"text":"Genotyping identified p.D1186H in the subject.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"},{"start":38,"end":45,"label":"PATIENT"}]}
{"text":"Sequencing revealed p.D1186H.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic variant, p.D1186H, was identified.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.D1186H was found in the patient.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"},{"start":34,"end":41,"label":"PATIENT"}]}
{"text":"p.D1186H emerged in our mitochondrial panel.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.D1186H was detected in the proband.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":30,"end":37,"label":"PATIENT"}]}
{"text":"Presence of p.D1186H was confirmed.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The patient harbored the p.D1186H substitution.","spans":[{"start":24,"end":32,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"p.D1186H is associated with clinical symptoms.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.D1186H likely contributes to disease onset.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Genotyping identified p.K512M in the subject.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"},{"start":36,"end":43,"label":"PATIENT"}]}
{"text":"Sequencing revealed p.K512M.","spans":[{"start":20,"end":26,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic variant, p.K512M, was identified.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.K512M was found in the patient.","spans":[{"start":9,"end":15,"label":"GENE_VARIANT"},{"start":32,"end":39,"label":"PATIENT"}]}
{"text":"p.K512M emerged in our mitochondrial panel.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"p.K512M was detected in the proband.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"},{"start":28,"end":35,"label":"PATIENT"}]}
{"text":"Presence of p.K512M was confirmed.","spans":[{"start":12,"end":18,"label":"GENE_VARIANT"}]}
{"text":"The patient harbored the p.K512M substitution.","spans":[{"start":24,"end":30,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"p.K512M is associated with clinical symptoms.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"p.K512M likely contributes to disease onset.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Genotyping identified p.S1095R in the subject.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"},{"start":38,"end":45,"label":"PATIENT"}]}
{"text":"Sequencing revealed p.S1095R.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic variant, p.S1095R, was identified.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.S1095R was found in the patient.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"},{"start":34,"end":41,"label":"PATIENT"}]}
{"text":"p.S1095R emerged in our mitochondrial panel.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.S1095R was detected in the proband.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":30,"end":37,"label":"PATIENT"}]}
{"text":"Presence of p.S1095R was confirmed.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The patient harbored the p.S1095R substitution.","spans":[{"start":24,"end":32,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"p.S1095R is associated with clinical symptoms.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.S1095R likely contributes to disease onset.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Genotyping identified p.I1185T in the subject.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"},{"start":38,"end":45,"label":"PATIENT"}]}
{"text":"Sequencing revealed p.I1185T.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic variant, p.I1185T, was identified.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.I1185T was found in the patient.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"},{"start":34,"end":41,"label":"PATIENT"}]}
{"text":"p.I1185T emerged in our mitochondrial panel.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.I1185T was detected in the proband.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":30,"end":37,"label":"PATIENT"}]}
{"text":"Presence of p.I1185T was confirmed.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The patient harbored the p.I1185T substitution.","spans":[{"start":24,"end":32,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"p.I1185T is associated with clinical symptoms.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.I1185T likely contributes to disease onset.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Genotyping identified p.A957V in the subject.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"},{"start":37,"end":44,"label":"PATIENT"}]}
{"text":"Sequencing revealed p.A957V.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic variant, p.A957V, was identified.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.A957V was found in the patient.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"},{"start":33,"end":40,"label":"PATIENT"}]}
{"text":"p.A957V emerged in our mitochondrial panel.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"p.A957V was detected in the proband.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":29,"end":36,"label":"PATIENT"}]}
{"text":"Presence of p.A957V was confirmed.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The patient harbored the p.A957V substitution.","spans":[{"start":24,"end":31,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"p.A957V is associated with clinical symptoms.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"p.A957V likely contributes to disease onset.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Clinical phenotypes have been linked to p.S1095R.","spans":[{"start":40,"end":48,"label":"GENE_VARIANT"}]}
{"text":"p.S1095R was recurrent in individuals undergoing genetic screening.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":27,"end":38,"label":"PATIENT"}]}
{"text":"We observed p.S1095R in a cohort of affected children.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"},{"start":43,"end":51,"label":"PATIENT"}]}
{"text":"Pathogenicity of p.S1095R was supported by functional assays.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"A variant such as p.S1095R may alter polymerase function.","spans":[{"start":18,"end":26,"label":"GENE_VARIANT"}]}
{"text":"Evidence suggests that p.S1095R disrupts replication fidelity.","spans":[{"start":23,"end":31,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.S1095R showed high conservation across species.","spans":[{"start":13,"end":21,"label":"GENE_VARIANT"}]}
{"text":"Based on prior studies, p.S1095R is likely disease-causing.","spans":[{"start":25,"end":33,"label":"GENE_VARIANT"}]}
{"text":"p.S1095R was implicated in multiple case reports.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.S1095R appeared recurrently in patients with mitochondrial disease.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":36,"end":44,"label":"PATIENT"}]}
{"text":"Clinical phenotypes have been linked to p.I1185T.","spans":[{"start":40,"end":48,"label":"GENE_VARIANT"}]}
{"text":"p.I1185T was recurrent in individuals undergoing genetic screening.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":27,"end":38,"label":"PATIENT"}]}
{"text":"We observed p.I1185T in a cohort of affected children.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"},{"start":43,"end":51,"label":"PATIENT"}]}
{"text":"Pathogenicity of p.I1185T was supported by functional assays.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"A variant such as p.I1185T may alter polymerase function.","spans":[{"start":18,"end":26,"label":"GENE_VARIANT"}]}
{"text":"Evidence suggests that p.I1185T disrupts replication fidelity.","spans":[{"start":23,"end":31,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.I1185T showed high conservation across species.","spans":[{"start":13,"end":21,"label":"GENE_VARIANT"}]}
{"text":"Based on prior studies, p.I1185T is likely disease-causing.","spans":[{"start":25,"end":33,"label":"GENE_VARIANT"}]}
{"text":"p.I1185T was implicated in multiple case reports.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"p.I1185T appeared recurrently in patients with mitochondrial disease.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":36,"end":44,"label":"PATIENT"}]}
{"text":"Clinical phenotypes have been linked to p.A957V.","spans":[{"start":40,"end":47,"label":"GENE_VARIANT"}]}
{"text":"p.A957V was recurrent in individuals undergoing genetic screening.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":26,"end":37,"label":"PATIENT"}]}
{"text":"We observed p.A957V in a cohort of affected children.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"},{"start":42,"end":50,"label":"PATIENT"}]}
{"text":"Pathogenicity of p.A957V was supported by functional assays.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"}]}
{"text":"A variant such as p.A957V may alter polymerase function.","spans":[{"start":18,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Evidence suggests that p.A957V disrupts replication fidelity.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.A957V showed high conservation across species.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"Based on prior studies, p.A957V is likely disease-causing.","spans":[{"start":25,"end":32,"label":"GENE_VARIANT"}]}
{"text":"p.A957V was implicated in multiple case reports.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"p.A957V appeared recurrently in patients with mitochondrial disease.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"},{"start":35,"end":43,"label":"PATIENT"}]}
{"text":"Clinical phenotypes have been linked to p.Gly848Ser.","spans":[{"start":40,"end":51,"label":"GENE_VARIANT"}]}
{"text":"p.Gly848Ser was recurrent in individuals undergoing genetic screening.","spans":[{"start":0,"end":11,"label":"GENE_VARIANT"},{"start":30,"end":41,"label":"PATIENT"}]}
{"text":"We observed p.Gly848Ser in a cohort of affected children.","spans":[{"start":12,"end":23,"label":"GENE_VARIANT"},{"start":46,"end":54,"label":"PATIENT"}]}
{"text":"Pathogenicity of p.Gly848Ser was supported by functional assays.","spans":[{"start":17,"end":28,"label":"GENE_VARIANT"}]}
{"text":"A variant such as p.Gly848Ser may alter polymerase function.","spans":[{"start":18,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Evidence suggests that p.Gly848Ser disrupts replication fidelity.","spans":[{"start":23,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.Gly848Ser showed high conservation across species.","spans":[{"start":13,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Based on prior studies, p.Gly848Ser is likely disease-causing.","spans":[{"start":25,"end":36,"label":"GENE_VARIANT"}]}
{"text":"p.Gly848Ser was implicated in multiple case reports.","spans":[{"start":0,"end":11,"label":"GENE_VARIANT"}]}
{"text":"p.Gly848Ser appeared recurrently in patients with mitochondrial disease.","spans":[{"start":0,"end":11,"label":"GENE_VARIANT"},{"start":39,"end":47,"label":"PATIENT"}]}
{"text":"Clinical phenotypes have been linked to pT914P.","spans":[{"start":40,"end":46,"label":"GENE_VARIANT"}]}
{"text":"pT914P was recurrent in individuals undergoing genetic screening.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"},{"start":25,"end":36,"label":"PATIENT"}]}
{"text":"We observed pT914P in a cohort of affected children.","spans":[{"start":12,"end":18,"label":"GENE_VARIANT"},{"start":41,"end":49,"label":"PATIENT"}]}
{"text":"Pathogenicity of pT914P was supported by functional assays.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"A variant such as pT914P may alter polymerase function.","spans":[{"start":18,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Evidence suggests that pT914P disrupts replication fidelity.","spans":[{"start":23,"end":29,"label":"GENE_VARIANT"}]}
{"text":"The mutation pT914P showed high conservation across species.","spans":[{"start":13,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Based on prior studies, pT914P is likely disease-causing.","spans":[{"start":25,"end":31,"label":"GENE_VARIANT"}]}
{"text":"pT914P was implicated in multiple case reports.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"pT914P appeared recurrently in patients with mitochondrial disease.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"},{"start":34,"end":42,"label":"PATIENT"}]}
{"text":"A substitution at c.1288A>T was noted in affected individuals.","spans":[{"start":18,"end":27,"label":"GENE_VARIANT"},{"start":44,"end":54,"label":"PATIENT"}]}
{"text":"Among the variants, c.1288A>T appeared recurrently.","spans":[{"start":20,"end":29,"label":"GENE_VARIANT"}]}
{"text":"c.1288A>T was observed during exome analysis.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening highlighted c.1288A>T as potentially pathogenic.","spans":[{"start":30,"end":39,"label":"GENE_VARIANT"}]}
{"text":"c.1288A>T emerged in patients with neurological symptoms.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"},{"start":19,"end":27,"label":"PATIENT"}]}
{"text":"Following sequencing, the c.1288A>T variant was reported.","spans":[{"start":26,"end":35,"label":"GENE_VARIANT"}]}
{"text":"Our results identified c.1288A>T in several probands.","spans":[{"start":24,"end":33,"label":"GENE_VARIANT"},{"start":45,"end":53,"label":"PATIENT"}]}
{"text":"Presence of c.1288A>T correlates with the clinical severity.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"}]}
{"text":"The alteration c.1288A>T may affect protein structure.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The variant c.1288A>T is frequently found in mtDNA analysis.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"}]}
{"text":"A substitution at c.2752T>C was noted in affected individuals.","spans":[{"start":18,"end":27,"label":"GENE_VARIANT"},{"start":44,"end":54,"label":"PATIENT"}]}
{"text":"Among the variants, c.2752T>C appeared recurrently.","spans":[{"start":20,"end":29,"label":"GENE_VARIANT"}]}
{"text":"c.2752T>C was observed during exome analysis.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening highlighted c.2752T>C as potentially pathogenic.","spans":[{"start":30,"end":39,"label":"GENE_VARIANT"}]}
{"text":"c.2752T>C emerged in patients with neurological symptoms.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"},{"start":19,"end":27,"label":"PATIENT"}]}
{"text":"Following sequencing, the c.2752T>C variant was reported.","spans":[{"start":26,"end":35,"label":"GENE_VARIANT"}]}
{"text":"Our results identified c.2752T>C in several probands.","spans":[{"start":24,"end":33,"label":"GENE_VARIANT"},{"start":45,"end":53,"label":"PATIENT"}]}
{"text":"Presence of c.2752T>C correlates with the clinical severity.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"}]}
{"text":"The alteration c.2752T>C may affect protein structure.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The variant c.2752T>C is frequently found in mtDNA analysis.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"}]}
{"text":"A substitution at c.752C>T was noted in affected individuals.","spans":[{"start":18,"end":26,"label":"GENE_VARIANT"},{"start":43,"end":53,"label":"PATIENT"}]}
{"text":"Among the variants, c.752C>T appeared recurrently.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"c.752C>T was observed during exome analysis.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening highlighted c.752C>T as potentially pathogenic.","spans":[{"start":30,"end":38,"label":"GENE_VARIANT"}]}
{"text":"c.752C>T emerged in patients with neurological symptoms.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"},{"start":18,"end":26,"label":"PATIENT"}]}
{"text":"Following sequencing, the c.752C>T variant was reported.","spans":[{"start":26,"end":34,"label":"GENE_VARIANT"}]}
{"text":"Our results identified c.752C>T in several probands.","spans":[{"start":24,"end":32,"label":"GENE_VARIANT"},{"start":44,"end":52,"label":"PATIENT"}]}
{"text":"Presence of c.752C>T correlates with the clinical severity.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"}]}
{"text":"The alteration c.752C>T may affect protein structure.","spans":[{"start":16,"end":24,"label":"GENE_VARIANT"}]}
{"text":"The variant c.752C>T is frequently found in mtDNA analysis.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"}]}
{"text":"A substitution at c.3626_3629dupGATA was noted in affected individuals.","spans":[{"start":18,"end":38,"label":"GENE_VARIANT"},{"start":55,"end":65,"label":"PATIENT"}]}
{"text":"Among the variants, c.3626_3629dupGATA appeared recurrently.","spans":[{"start":20,"end":40,"label":"GENE_VARIANT"}]}
{"text":"c.3626_3629dupGATA was observed during exome analysis.","spans":[{"start":0,"end":20,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening highlighted c.3626_3629dupGATA as potentially pathogenic.","spans":[{"start":30,"end":50,"label":"GENE_VARIANT"}]}
{"text":"c.3626_3629dupGATA emerged in patients with neurological symptoms.","spans":[{"start":0,"end":20,"label":"GENE_VARIANT"},{"start":30,"end":38,"label":"PATIENT"}]}
{"text":"Following sequencing, the c.3626_3629dupGATA variant was reported.","spans":[{"start":26,"end":46,"label":"GENE_VARIANT"}]}
{"text":"Our results identified c.3626_3629dupGATA in several probands.","spans":[{"start":24,"end":44,"label":"GENE_VARIANT"},{"start":56,"end":64,"label":"PATIENT"}]}
{"text":"Presence of c.3626_3629dupGATA correlates with the clinical severity.","spans":[{"start":12,"end":32,"label":"GENE_VARIANT"}]}
{"text":"The alteration c.3626_3629dupGATA may affect protein structure.","spans":[{"start":16,"end":36,"label":"GENE_VARIANT"}]}
{"text":"The variant c.3626_3629dupGATA is frequently found in mtDNA analysis.","spans":[{"start":12,"end":32,"label":"GENE_VARIANT"}]}
{"text":"A substitution at c.2993C>T was noted in affected individuals.","spans":[{"start":18,"end":27,"label":"GENE_VARIANT"},{"start":44,"end":54,"label":"PATIENT"}]}
{"text":"Among the variants, c.2993C>T appeared recurrently.","spans":[{"start":20,"end":29,"label":"GENE_VARIANT"}]}
{"text":"c.2993C>T was observed during exome analysis.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening highlighted c.2993C>T as potentially pathogenic.","spans":[{"start":30,"end":39,"label":"GENE_VARIANT"}]}
{"text":"c.2993C>T emerged in patients with neurological symptoms.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"},{"start":19,"end":27,"label":"PATIENT"}]}
{"text":"Following sequencing, the c.2993C>T variant was reported.","spans":[{"start":26,"end":35,"label":"GENE_VARIANT"}]}
{"text":"Our results identified c.2993C>T in several probands.","spans":[{"start":24,"end":33,"label":"GENE_VARIANT"},{"start":45,"end":53,"label":"PATIENT"}]}
{"text":"Presence of c.2993C>T correlates with the clinical severity.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"}]}
{"text":"The alteration c.2993C>T may affect protein structure.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The variant c.2993C>T is frequently found in mtDNA analysis.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"}]}
{"text":"c.3550G>C is suspected to interfere with gene expression.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Cases involving c.3550G>C often exhibit early-onset signs.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":5,"label":"PATIENT"}]}
{"text":"Variants like c.3550G>C have clinical implications.","spans":[{"start":14,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The mutation identified was c.3550G>C, linked to disease.","spans":[{"start":28,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Functional studies highlighted c.3550G>C as deleterious.","spans":[{"start":31,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Rare mutations such as c.3550G>C demand further evaluation.","spans":[{"start":23,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Our screening protocol detected c.3550G>C in patients.","spans":[{"start":32,"end":41,"label":"GENE_VARIANT"},{"start":45,"end":53,"label":"PATIENT"}]}
{"text":"Researchers noted c.3550G>C in mitochondrial disorder cases.","spans":[{"start":18,"end":27,"label":"GENE_VARIANT"},{"start":50,"end":55,"label":"PATIENT"}]}
{"text":"A child carrying the c.3550G>C variant presented symptoms.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"c.3550G>C accounts for a common genetic lesion.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"c.1760C>T is suspected to interfere with gene expression.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Cases involving c.1760C>T often exhibit early-onset signs.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":5,"label":"PATIENT"}]}
{"text":"Variants like c.1760C>T have clinical implications.","spans":[{"start":14,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The mutation identified was c.1760C>T, linked to disease.","spans":[{"start":28,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Functional studies highlighted c.1760C>T as deleterious.","spans":[{"start":31,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Rare mutations such as c.1760C>T demand further evaluation.","spans":[{"start":23,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Our screening protocol detected c.1760C>T in patients.","spans":[{"start":32,"end":41,"label":"GENE_VARIANT"},{"start":45,"end":53,"label":"PATIENT"}]}
{"text":"Researchers noted c.1760C>T in mitochondrial disorder cases.","spans":[{"start":18,"end":27,"label":"GENE_VARIANT"},{"start":50,"end":55,"label":"PATIENT"}]}
{"text":"A child carrying the c.1760C>T variant presented symptoms.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"c.1760C>T accounts for a common genetic lesion.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"c.3572A>G is suspected to interfere with gene expression.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Cases involving c.3572A>G often exhibit early-onset signs.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":5,"label":"PATIENT"}]}
{"text":"Variants like c.3572A>G have clinical implications.","spans":[{"start":14,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The mutation identified was c.3572A>G, linked to disease.","spans":[{"start":28,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Functional studies highlighted c.3572A>G as deleterious.","spans":[{"start":31,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Rare mutations such as c.3572A>G demand further evaluation.","spans":[{"start":23,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Our screening protocol detected c.3572A>G in patients.","spans":[{"start":32,"end":41,"label":"GENE_VARIANT"},{"start":45,"end":53,"label":"PATIENT"}]}
{"text":"Researchers noted c.3572A>G in mitochondrial disorder cases.","spans":[{"start":18,"end":27,"label":"GENE_VARIANT"},{"start":50,"end":55,"label":"PATIENT"}]}
{"text":"A child carrying the c.3572A>G variant presented symptoms.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"c.3572A>G accounts for a common genetic lesion.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"c.2542G>A is suspected to interfere with gene expression.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Cases involving c.2542G>A often exhibit early-onset signs.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":5,"label":"PATIENT"}]}
{"text":"Variants like c.2542G>A have clinical implications.","spans":[{"start":14,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The mutation identified was c.2542G>A, linked to disease.","spans":[{"start":28,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Functional studies highlighted c.2542G>A as deleterious.","spans":[{"start":31,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Rare mutations such as c.2542G>A demand further evaluation.","spans":[{"start":23,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Our screening protocol detected c.2542G>A in patients.","spans":[{"start":32,"end":41,"label":"GENE_VARIANT"},{"start":45,"end":53,"label":"PATIENT"}]}
{"text":"Researchers noted c.2542G>A in mitochondrial disorder cases.","spans":[{"start":18,"end":27,"label":"GENE_VARIANT"},{"start":50,"end":55,"label":"PATIENT"}]}
{"text":"A child carrying the c.2542G>A variant presented symptoms.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"c.2542G>A accounts for a common genetic lesion.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"c.3643+2TNC is suspected to interfere with gene expression.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Cases involving c.3643+2TNC often exhibit early-onset signs.","spans":[{"start":16,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":5,"label":"PATIENT"}]}
{"text":"Variants like c.3643+2TNC have clinical implications.","spans":[{"start":14,"end":26,"label":"GENE_VARIANT"}]}
{"text":"The mutation identified was c.3643+2TNC, linked to disease.","spans":[{"start":28,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Functional studies highlighted c.3643+2TNC as deleterious.","spans":[{"start":31,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Rare mutations such as c.3643+2TNC demand further evaluation.","spans":[{"start":23,"end":35,"label":"GENE_VARIANT"}]}
{"text":"Our screening protocol detected c.3643+2TNC in patients.","spans":[{"start":32,"end":44,"label":"GENE_VARIANT"},{"start":48,"end":56,"label":"PATIENT"}]}
{"text":"Researchers noted c.3643+2TNC in mitochondrial disorder cases.","spans":[{"start":18,"end":30,"label":"GENE_VARIANT"},{"start":53,"end":58,"label":"PATIENT"}]}
{"text":"A child carrying the c.3643+2TNC variant presented symptoms.","spans":[{"start":21,"end":33,"label":"GENE_VARIANT"},{"start":2,"end":7,"label":"PATIENT"}]}
{"text":"c.3643+2TNC accounts for a common genetic lesion.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"}]}
{"text":"c.2243G>C alteration may be responsible for early-onset symptoms.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"A mutation designated c.2243G>C was seen in multiple siblings.","spans":[{"start":22,"end":31,"label":"GENE_VARIANT"},{"start":49,"end":57,"label":"PATIENT"}]}
{"text":"There is growing evidence supporting c.2243G>C as pathogenic.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"}]}
{"text":"Inheritance of c.2243G>C appears to follow autosomal recessive mode.","spans":[{"start":15,"end":24,"label":"GENE_VARIANT"}]}
{"text":"c.2243G>C represents a rare pathogenic variant in this disorder.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The variant c.2243G>C is consistently found in symptomatic patients.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"},{"start":52,"end":60,"label":"PATIENT"}]}
{"text":"Detection of c.2243G>C helped clarify the patient’s condition.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":42,"end":49,"label":"PATIENT"}]}
{"text":"Recent studies associate c.2243G>C with mitochondrial dysfunction.","spans":[{"start":25,"end":34,"label":"GENE_VARIANT"}]}
{"text":"c.2243G>C has been linked to progressive neurological decline.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Next-generation sequencing revealed c.2243G>C in the cohort.","spans":[{"start":34,"end":43,"label":"GENE_VARIANT"},{"start":51,"end":57,"label":"PATIENT"}]}
{"text":"c.1156C>T alteration may be responsible for early-onset symptoms.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"A mutation designated c.1156C>T was seen in multiple siblings.","spans":[{"start":22,"end":31,"label":"GENE_VARIANT"},{"start":49,"end":57,"label":"PATIENT"}]}
{"text":"There is growing evidence supporting c.1156C>T as pathogenic.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"}]}
{"text":"Inheritance of c.1156C>T appears to follow autosomal recessive mode.","spans":[{"start":15,"end":24,"label":"GENE_VARIANT"}]}
{"text":"c.1156C>T represents a rare pathogenic variant in this disorder.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The variant c.1156C>T is consistently found in symptomatic patients.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"},{"start":52,"end":60,"label":"PATIENT"}]}
{"text":"Detection of c.1156C>T helped clarify the patient’s condition.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":42,"end":49,"label":"PATIENT"}]}
{"text":"Recent studies associate c.1156C>T with mitochondrial dysfunction.","spans":[{"start":25,"end":34,"label":"GENE_VARIANT"}]}
{"text":"c.1156C>T has been linked to progressive neurological decline.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Next-generation sequencing revealed c.1156C>T in the cohort.","spans":[{"start":34,"end":43,"label":"GENE_VARIANT"},{"start":51,"end":57,"label":"PATIENT"}]}
{"text":"c.2794C>T alteration may be responsible for early-onset symptoms.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"A mutation designated c.2794C>T was seen in multiple siblings.","spans":[{"start":22,"end":31,"label":"GENE_VARIANT"},{"start":49,"end":57,"label":"PATIENT"}]}
{"text":"There is growing evidence supporting c.2794C>T as pathogenic.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"}]}
{"text":"Inheritance of c.2794C>T appears to follow autosomal recessive mode.","spans":[{"start":15,"end":24,"label":"GENE_VARIANT"}]}
{"text":"c.2794C>T represents a rare pathogenic variant in this disorder.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The variant c.2794C>T is consistently found in symptomatic patients.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"},{"start":52,"end":60,"label":"PATIENT"}]}
{"text":"Detection of c.2794C>T helped clarify the patient’s condition.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":42,"end":49,"label":"PATIENT"}]}
{"text":"Recent studies associate c.2794C>T with mitochondrial dysfunction.","spans":[{"start":25,"end":34,"label":"GENE_VARIANT"}]}
{"text":"c.2794C>T has been linked to progressive neurological decline.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Next-generation sequencing revealed c.2794C>T in the cohort.","spans":[{"start":34,"end":43,"label":"GENE_VARIANT"},{"start":51,"end":57,"label":"PATIENT"}]}
{"text":"c.2584G>A alteration may be responsible for early-onset symptoms.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"A mutation designated c.2584G>A was seen in multiple siblings.","spans":[{"start":22,"end":31,"label":"GENE_VARIANT"},{"start":49,"end":57,"label":"PATIENT"}]}
{"text":"There is growing evidence supporting c.2584G>A as pathogenic.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"}]}
{"text":"Inheritance of c.2584G>A appears to follow autosomal recessive mode.","spans":[{"start":15,"end":24,"label":"GENE_VARIANT"}]}
{"text":"c.2584G>A represents a rare pathogenic variant in this disorder.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The variant c.2584G>A is consistently found in symptomatic patients.","spans":[{"start":12,"end":21,"label":"GENE_VARIANT"},{"start":52,"end":60,"label":"PATIENT"}]}
{"text":"Detection of c.2584G>A helped clarify the patient’s condition.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":42,"end":49,"label":"PATIENT"}]}
{"text":"Recent studies associate c.2584G>A with mitochondrial dysfunction.","spans":[{"start":25,"end":34,"label":"GENE_VARIANT"}]}
{"text":"c.2584G>A has been linked to progressive neurological decline.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Next-generation sequencing revealed c.2584G>A in the cohort.","spans":[{"start":34,"end":43,"label":"GENE_VARIANT"},{"start":51,"end":57,"label":"PATIENT"}]}
{"text":"c.830A>T alteration may be responsible for early-onset symptoms.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"A mutation designated c.830A>T was seen in multiple siblings.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"},{"start":48,"end":56,"label":"PATIENT"}]}
{"text":"There is growing evidence supporting c.830A>T as pathogenic.","spans":[{"start":37,"end":45,"label":"GENE_VARIANT"}]}
{"text":"Inheritance of c.830A>T appears to follow autosomal recessive mode.","spans":[{"start":15,"end":23,"label":"GENE_VARIANT"}]}
{"text":"c.830A>T represents a rare pathogenic variant in this disorder.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"The variant c.830A>T is consistently found in symptomatic patients.","spans":[{"start":12,"end":20,"label":"GENE_VARIANT"},{"start":51,"end":59,"label":"PATIENT"}]}
{"text":"Detection of c.830A>T helped clarify the patient’s condition.","spans":[{"start":13,"end":21,"label":"GENE_VARIANT"},{"start":41,"end":48,"label":"PATIENT"}]}
{"text":"Recent studies associate c.830A>T with mitochondrial dysfunction.","spans":[{"start":25,"end":33,"label":"GENE_VARIANT"}]}
{"text":"c.830A>T has been linked to progressive neurological decline.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Next-generation sequencing revealed c.830A>T in the cohort.","spans":[{"start":34,"end":42,"label":"GENE_VARIANT"},{"start":50,"end":56,"label":"PATIENT"}]}
{"text": "The substitution c.1399G>A was detected in muscle biopsy samples.", "spans": [{"start": 17, "end": 26, "label": "GENE_VARIANT"}]}
{"text": "Symptoms correlated strongly with c.1399G>A presence.", "spans": [{"start": 34, "end": 43, "label": "GENE_VARIANT"}]}
{"text": "c.1399G>A has emerged as a variant of uncertain significance.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "c.1399G>A was observed alongside clinical deterioration.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "In several patients, c.1399G>A was the only identified mutation.", "spans": [{"start": 21, "end": 30, "label": "GENE_VARIANT"}, {"start": 12, "end": 20, "label": "PATIENT"}]}
{"text": "Individuals carrying c.1399G>A often manifest early symptoms.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}, {"start": 0, "end": 11, "label": "PATIENT"}]}
{"text": "Genetic panels frequently detect c.1399G>A in mitochondrial cases.", "spans": [{"start": 33, "end": 42, "label": "GENE_VARIANT"}]}
{"text": "c.1399G>A was consistently reported in affected individuals.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 44, "end": 55, "label": "PATIENT"}]}
{"text": "The case study revealed c.1399G>A among compound heterozygotes.", "spans": [{"start": 25, "end": 34, "label": "GENE_VARIANT"}]}
{"text": "Mutational analysis confirmed c.1399G>A in the cohort.", "spans": [{"start": 30, "end": 39, "label": "GENE_VARIANT"}, {"start": 47, "end": 53, "label": "PATIENT"}]}
{"text": "The substitution c.1535A>T was detected in muscle biopsy samples.", "spans": [{"start": 17, "end": 26, "label": "GENE_VARIANT"}]}
{"text": "Symptoms correlated strongly with c.1535A>T presence.", "spans": [{"start": 34, "end": 43, "label": "GENE_VARIANT"}]}
{"text": "c.1535A>T has emerged as a variant of uncertain significance.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "c.1535A>T was observed alongside clinical deterioration.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "In several patients, c.1535A>T was the only identified mutation.", "spans": [{"start": 21, "end": 30, "label": "GENE_VARIANT"}, {"start": 12, "end": 20, "label": "PATIENT"}]}
{"text": "Individuals carrying c.1535A>T often manifest early symptoms.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}, {"start": 0, "end": 11, "label": "PATIENT"}]}
{"text": "Genetic panels frequently detect c.1535A>T in mitochondrial cases.", "spans": [{"start": 33, "end": 42, "label": "GENE_VARIANT"}]}
{"text": "c.1535A>T was consistently reported in affected individuals.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 44, "end": 55, "label": "PATIENT"}]}
{"text": "The case study revealed c.1535A>T among compound heterozygotes.", "spans": [{"start": 25, "end": 34, "label": "GENE_VARIANT"}]}
{"text": "Mutational analysis confirmed c.1535A>T in the cohort.", "spans": [{"start": 30, "end": 39, "label": "GENE_VARIANT"}, {"start": 47, "end": 53, "label": "PATIENT"}]}
{"text": "The c.3286C>T mutation disrupts protein stability in patients.", "spans": [{"start": 4, "end": 13, "label": "GENE_VARIANT"}, {"start": 53, "end": 61, "label": "PATIENT"}]}
{"text": "In patient cohorts, c.3286C>T has been noted repeatedly.", "spans": [{"start": 3, "end": 10, "label": "PATIENT"}, {"start": 11, "end": 18, "label": "PATIENT"}, {"start": 20, "end": 29, "label": "GENE_VARIANT"}]}
{"text": "Our data implicate c.3286C>T in the pathogenesis of the disease.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}]}
{"text": "Further investigation confirmed c.3286C>T in symptomatic individuals.", "spans": [{"start": 32, "end": 41, "label": "GENE_VARIANT"}, {"start": 57, "end": 68, "label": "PATIENT"}]}
{"text": "Analysis pinpointed c.3286C>T as a recurrent variant.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}]}
{"text": "Biochemical assays revealed the impact of c.3286C>T.", "spans": [{"start": 42, "end": 51, "label": "GENE_VARIANT"}]}
{"text": "The evidence base for c.3286C>T includes multiple families.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}, {"start": 50, "end": 58, "label": "PATIENT"}]}
{"text": "Clinical reports often cite c.3286C>T in related disorders.", "spans": [{"start": 28, "end": 37, "label": "GENE_VARIANT"}]}
{"text": "Pathogenicity of c.3286C>T is supported by familial segregation.", "spans": [{"start": 17, "end": 26, "label": "GENE_VARIANT"}]}
{"text": "The identification of c.3286C>T supports a mitochondrial etiology.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}]}
{"text": "Our data implicate c.3554T>C in the pathogenesis of the disease.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}]}
{"text": "Further investigation confirmed c.3554T>C in symptomatic individuals.", "spans": [{"start": 32, "end": 41, "label": "GENE_VARIANT"}, {"start": 57, "end": 68, "label": "PATIENT"}]}
{"text": "The identification of c.3554T>C supports a mitochondrial etiology.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}]}
{"text": "Analysis pinpointed c.3554T>C as a recurrent variant.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}]}
{"text": "Biochemical assays revealed the impact of c.3554T>C.", "spans": [{"start": 42, "end": 51, "label": "GENE_VARIANT"}]}
{"text": "The c.3554T>C mutation disrupts protein stability in patients.", "spans": [{"start": 4, "end": 13, "label": "GENE_VARIANT"}, {"start": 53, "end": 61, "label": "PATIENT"}]}
{"text": "The evidence base for c.3554T>C includes multiple families.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}, {"start": 50, "end": 58, "label": "PATIENT"}]}
{"text": "In patient cohorts, c.3554T>C has been noted repeatedly.", "spans": [{"start": 3, "end": 10, "label": "PATIENT"}, {"start": 11, "end": 18, "label": "PATIENT"}, {"start": 20, "end": 29, "label": "GENE_VARIANT"}]}
{"text": "Pathogenicity of c.3554T>C is supported by familial segregation.", "spans": [{"start": 17, "end": 26, "label": "GENE_VARIANT"}]}
{"text": "Clinical reports often cite c.3554T>C in related disorders.", "spans": [{"start": 28, "end": 37, "label": "GENE_VARIANT"}]}
{"text": "The identification of c.2870C>T supports a mitochondrial etiology.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}]}
{"text": "Biochemical assays revealed the impact of c.2870C>T.", "spans": [{"start": 42, "end": 51, "label": "GENE_VARIANT"}]}
{"text": "Clinical reports often cite c.2870C>T in related disorders.", "spans": [{"start": 28, "end": 37, "label": "GENE_VARIANT"}]}
{"text": "Our data implicate c.2870C>T in the pathogenesis of the disease.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}]}
{"text": "The c.2870C>T mutation disrupts protein stability in patients.", "spans": [{"start": 4, "end": 13, "label": "GENE_VARIANT"}, {"start": 53, "end": 61, "label": "PATIENT"}]}
{"text": "Further investigation confirmed c.2870C>T in symptomatic individuals.", "spans": [{"start": 32, "end": 41, "label": "GENE_VARIANT"}, {"start": 57, "end": 68, "label": "PATIENT"}]}
{"text": "Analysis pinpointed c.2870C>T as a recurrent variant.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}]}
{"text": "Pathogenicity of c.2870C>T is supported by familial segregation.", "spans": [{"start": 17, "end": 26, "label": "GENE_VARIANT"}]}
{"text": "In patient cohorts, c.2870C>T has been noted repeatedly.", "spans": [{"start": 3, "end": 10, "label": "PATIENT"}, {"start": 11, "end": 18, "label": "PATIENT"}, {"start": 20, "end": 29, "label": "GENE_VARIANT"}]}
{"text": "The evidence base for c.2870C>T includes multiple families.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}, {"start": 50, "end": 58, "label": "PATIENT"}]}
{"text": "c.2870C>T has been linked to severe mitochondrial dysfunction.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "c.2870C>T co-segregated with the phenotype in multiple families.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 55, "end": 63, "label": "PATIENT"}]}
{"text": "Pathogenic effects of c.2870C>T were supported by functional assays.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}]}
{"text": "c.2870C>T emerged as the most plausible cause in the patient.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 53, "end": 60, "label": "PATIENT"}]}
{"text": "c.2870C>T was uncovered during NGS panel analysis.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "A recurrent event, c.2870C>T contributes to disease onset.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}]}
{"text": "We detected c.2870C>T in several unrelated families.", "spans": [{"start": 12, "end": 21, "label": "GENE_VARIANT"}, {"start": 43, "end": 51, "label": "PATIENT"}]}
{"text": "The patient carried c.2870C>T without other pathogenic variants.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}, {"start": 4, "end": 11, "label": "PATIENT"}]}
{"text": "c.2870C>T alters splicing and impairs gene function.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "Studies identified c.2870C>T in affected individuals.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}, {"start": 41, "end": 52, "label": "PATIENT"}]}
{"text": "c.2864A>G alters splicing and impairs gene function.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "The patient carried c.2864A>G without other pathogenic variants.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}, {"start": 4, "end": 11, "label": "PATIENT"}]}
{"text": "Pathogenic effects of c.2864A>G were supported by functional assays.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}]}
{"text": "We detected c.2864A>G in several unrelated families.", "spans": [{"start": 12, "end": 21, "label": "GENE_VARIANT"}, {"start": 43, "end": 51, "label": "PATIENT"}]}
{"text": "c.2864A>G emerged as the most plausible cause in the patient.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 53, "end": 60, "label": "PATIENT"}]}
{"text": "Studies identified c.2864A>G in affected individuals.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}, {"start": 41, "end": 52, "label": "PATIENT"}]}
{"text": "c.2864A>G was uncovered during NGS panel analysis.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "c.2864A>G has been linked to severe mitochondrial dysfunction.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "A recurrent event, c.2864A>G contributes to disease onset.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}]}
{"text": "c.2864A>G co-segregated with the phenotype in multiple families.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 55, "end": 63, "label": "PATIENT"}]}
{"text": "c.1399G>A has been linked to severe mitochondrial dysfunction.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "We detected c.1399G>A in several unrelated families.", "spans": [{"start": 12, "end": 21, "label": "GENE_VARIANT"}, {"start": 43, "end": 51, "label": "PATIENT"}]}
{"text": "Studies identified c.1399G>A in affected individuals.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}, {"start": 41, "end": 52, "label": "PATIENT"}]}
{"text": "c.1399G>A co-segregated with the phenotype in multiple families.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 55, "end": 63, "label": "PATIENT"}]}
{"text": "c.1399G>A was uncovered during NGS panel analysis.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "The patient carried c.1399G>A without other pathogenic variants.", "spans": [{"start": 20, "end": 29, "label": "GENE_VARIANT"}, {"start": 4, "end": 11, "label": "PATIENT"}]}
{"text": "Pathogenic effects of c.1399G>A were supported by functional assays.", "spans": [{"start": 22, "end": 31, "label": "GENE_VARIANT"}]}
{"text": "A recurrent event, c.1399G>A contributes to disease onset.", "spans": [{"start": 19, "end": 28, "label": "GENE_VARIANT"}]}
{"text": "c.1399G>A alters splicing and impairs gene function.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}]}
{"text": "c.1399G>A emerged as the most plausible cause in the patient.", "spans": [{"start": 0, "end": 9, "label": "GENE_VARIANT"}, {"start": 53, "end": 60, "label": "PATIENT"}]}
{"text": "Deletion of exons 15–21 emerged as a potential pathogenic alteration.", "spans": [{"start": 0, "end": 25, "label": "GENE_VARIANT"}]}
{"text": "The patient carried Deletion of exons 15–21 without other mutations.", "spans": [{"start": 20, "end": 45, "label": "GENE_VARIANT"}, {"start": 4, "end": 11, "label": "PATIENT"}]}
{"text": "We detected Deletion of exons 15–21 in several unrelated families.", "spans": [{"start": 12, "end": 37, "label": "GENE_VARIANT"}, {"start": 59, "end": 67, "label": "PATIENT"}]}
{"text": "Deletion of exons 15–21 co-segregated with the phenotype in multiple families.", "spans": [{"start": 0, "end": 25, "label": "GENE_VARIANT"}, {"start": 71, "end": 79, "label": "PATIENT"}]}
{"text": "Pathogenic effects of Deletion of exons 15–21 were demonstrated.", "spans": [{"start": 22, "end": 47, "label": "GENE_VARIANT"}]}
{"text": "Studies identified Deletion of exons 15–21 in affected individuals.", "spans": [{"start": 19, "end": 44, "label": "GENE_VARIANT"}, {"start": 56, "end": 67, "label": "PATIENT"}]}
{"text": "Exon 22 skipping alters splicing and impairs gene function.", "spans": [{"start": 0, "end": 18, "label": "GENE_VARIANT"}]}
{"text": "We detected Exon 22 skipping in several unrelated families.", "spans": [{"start": 12, "end": 30, "label": "GENE_VARIANT"}, {"start": 52, "end": 60, "label": "PATIENT"}]}
{"text": "The patient carried Exon 22 skipping without other mutations.", "spans": [{"start": 20, "end": 38, "label": "GENE_VARIANT"}, {"start": 4, "end": 11, "label": "PATIENT"}]}
{"text": "Exon 22 skipping emerged as the most plausible cause in the patient.", "spans": [{"start": 0, "end": 18, "label": "GENE_VARIANT"}, {"start": 60, "end": 67, "label": "PATIENT"}]}
{"text": "Pathogenic effects of Exon 22 skipping were demonstrated.", "spans": [{"start": 22, "end": 40, "label": "GENE_VARIANT"}]}
{"text": "Intragenic deletion (~4.7 kb) co-segregated with the phenotype.", "spans": [{"start": 0, "end": 30, "label": "GENE_VARIANT"}]}
{"text": "Pathogenic effects of Intragenic deletion (~4.7 kb) were supported by functional assays.", "spans": [{"start": 22, "end": 52, "label": "GENE_VARIANT"}]}
{"text": "We detected Intragenic deletion (~4.7 kb) in unrelated families.", "spans": [{"start": 12, "end": 42, "label": "GENE_VARIANT"}, {"start": 46, "end": 54, "label": "PATIENT"}]}
{"text": "Intragenic deletion (~4.7 kb) emerged as a disease-linked alteration.", "spans": [{"start": 0, "end": 30, "label": "GENE_VARIANT"}]}
{"text": "The patient carried Intragenic deletion (~4.7 kb).", "spans": [{"start": 20, "end": 50, "label": "GENE_VARIANT"}, {"start": 4, "end": 11, "label": "PATIENT"}]}
{"text": "Studies identified Intragenic deletion (~4.7 kb) in individuals.", "spans": [{"start": 19, "end": 49, "label": "GENE_VARIANT"}, {"start": 53, "end": 64, "label": "PATIENT"}]}
{"text":"The p.A467T mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.A467T as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.A467T was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.A467T may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.A467T is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.A467T was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.A467T is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.A467T was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.A467T is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.A467T in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.W748S mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.W748S as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.W748S was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.W748S may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.W748S is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.W748S was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.W748S is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.W748S was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.W748S is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.W748S in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.T251I mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.T251I as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.T251I was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.T251I may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.T251I is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.T251I was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.T251I is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.T251I was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.T251I is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.T251I in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.P587L mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.P587L as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.P587L was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.P587L may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.P587L is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.P587L was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.P587L is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.P587L was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.P587L is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.P587L in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"The p.G848S mutation was detected in the recent genetic test.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Researchers identified p.G848S as a likely pathogenic variant.","spans":[{"start":23,"end":30,"label":"GENE_VARIANT"}]}
{"text":"In this patient, p.G848S was the only variant observed.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":11,"end":18,"label":"PATIENT"}]}
{"text":"Analysis showed that p.G848S may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"If p.G848S is present, further clinical evaluation is recommended.","spans":[{"start":3,"end":10,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, the variant p.G848S was already known.","spans":[{"start":27,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.G848S is frequently reported in POLG-related disorders.","spans":[{"start":13,"end":20,"label":"GENE_VARIANT"}]}
{"text":"When p.G848S was identified, treatment adjustments were made.","spans":[{"start":5,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Clinically, p.G848S is correlated with early-onset symptoms in the child.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"},{"start":63,"end":68,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of p.G848S in the patient who died at 5.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":46,"end":53,"label":"PATIENT"},{"start":58,"end":68,"label":"AGE_DEATH"}]}
{"text":"Clinically, p.W918R is associated with progressive neurological decline.","spans":[{"start":11,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Functional assays demonstrate that p.W918R impairs enzymatic activity.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Analysis showed that p.T251I may be associated with mitochondrial dysfunction.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"The A467T variant was identified in the patient’s genome.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis confirmed the presence of A467T.","spans":[{"start":40,"end":45,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the pathogenic A467T mutation.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"At diagnosis, the A467T mutation was already known.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"A467T was found to be associated with early-onset symptoms.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing revealed A467T as a likely pathogenic allele.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The presence of A467T explains the patient's phenotype.","spans":[{"start":16,"end":21,"label":"GENE_VARIANT"},{"start":35,"end":42,"label":"PATIENT"}]}
{"text":"Genetic testing showed that she harbored A467T.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"},{"start":32,"end":35,"label":"PATIENT"}]}
{"text":"The A467T mutation was first described in this family.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for A467T was confirmed by clinical sequencing.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The W748S variant has been linked to mitochondrial disease.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried a heterozygous W748S mutation.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"W748S was confirmed by Sanger sequencing.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified W748S as the causative variant.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"}]}
{"text":"The presence of W748S supports the clinical suspicion.","spans":[{"start":16,"end":21,"label":"GENE_VARIANT"}]}
{"text":"W748S was inherited from the maternal allele.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The W748S mutation correlated with a severe phenotype.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the W748S variant.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A pathogenic W748S mutation was detected in testing.","spans":[{"start":13,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing revealed a homozygous W748S mutation.","spans":[{"start":35,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The T251I mutation was first documented in 2004.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"A heterozygous T251I variant was identified in this case.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"T251I was present in both alleles of the patient.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"},{"start":36,"end":43,"label":"PATIENT"}]}
{"text":"She carried the rare T251I mutation in POLG1.","spans":[{"start":24,"end":29,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the T251I variant in exon 2.","spans":[{"start":23,"end":28,"label":"GENE_VARIANT"}]}
{"text":"T251I has been linked to ataxia and epilepsy.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic T251I allele was inherited maternally.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for T251I was confirmed through testing.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"T251I was detected in the proband's mitochondrial genome.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The patient was diagnosed with a T251I mutation.","spans":[{"start":32,"end":37,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"P587L was discovered in a screen of mitochondrial genes.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The patient carried a heterozygous P587L mutation.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"She harbored a pathogenic variant: P587L.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The P587L mutation was inherited in an autosomal recessive pattern.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis identified the P587L variant in exon 3.","spans":[{"start":28,"end":33,"label":"GENE_VARIANT"}]}
{"text":"P587L was linked to neurodegenerative symptoms.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing results showed the presence of P587L.","spans":[{"start":38,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Her symptoms were associated with P587L mutation.","spans":[{"start":33,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A homozygous P587L variant was detected in the child.","spans":[{"start":13,"end":18,"label":"GENE_VARIANT"},{"start":41,"end":46,"label":"PATIENT"}]}
{"text":"The pathogenic role of P587L was supported by evidence.","spans":[{"start":23,"end":28,"label":"GENE_VARIANT"}]}
{"text":"G848S was identified as a pathogenic mutation in POLG.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The patient was heterozygous for G848S.","spans":[{"start":31,"end":36,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"She carried the G848S mutation on one allele.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Genetic sequencing confirmed the G848S substitution.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"}]}
{"text":"The G848S variant was linked to neurodegeneration.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Clinical analysis revealed a homozygous G848S mutation.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"}]}
{"text":"Mutation G848S was identified in the patient sample.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, G848S was found in the child’s DNA.","spans":[{"start":13,"end":18,"label":"GENE_VARIANT"},{"start":35,"end":40,"label":"PATIENT"}]}
{"text":"The boy was diagnosed with a G848S variant.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"},{"start":4,"end":7,"label":"PATIENT"}]}
{"text":"Presence of G848S mutation explained her clinical symptoms.","spans":[{"start":12,"end":17,"label":"GENE_VARIANT"},{"start":41,"end":44,"label":"PATIENT"}]}
{"text":"The p.P587L substitution was identified in the POLG gene.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Genetic sequencing confirmed a pathogenic p.P587L variant.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 was homozygous for the p.P587L mutation.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense mutation p.P587L altered the polymerase domain.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"p.P587L is a well-documented mutation associated with ataxia.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed the presence of p.P587L.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.P587L was found in exon 3 of POLG.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"She was identified as a carrier of the p.P587L variant.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The pathogenic variant p.P587L was inherited maternally.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"p.P587L has been implicated in early-onset mitochondrial disorders.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"The p.G848S variant affects a conserved residue in POLG.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified p.G848S as a likely pathogenic mutation.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The p.G848S substitution was located within the polymerase domain.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 was compound heterozygous, carrying p.G848S.","spans":[{"start":43,"end":50,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Mutation p.G848S was reported in previous POLG studies.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"A highly conserved site is disrupted by p.G848S.","spans":[{"start":37,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Her clinical presentation was consistent with p.G848S.","spans":[{"start":43,"end":50,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for p.G848S was detected during testing.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"}]}
{"text":"p.G848S was classified as a deleterious mutation.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"The boy was found to carry the pathogenic p.G848S variant.","spans":[{"start":41,"end":48,"label":"GENE_VARIANT"},{"start":4,"end":7,"label":"PATIENT"}]}
{"text":"The p.A467T mutation is a common variant in POLG-related disorders.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis confirmed compound heterozygosity for p.A467T.","spans":[{"start":48,"end":55,"label":"GENE_VARIANT"}]}
{"text":"p.A467T affects a residue critical for polymerase activity.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 carried the p.A467T mutation along with another variant.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"A missense mutation at p.A467T was found to be pathogenic.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.A467T was identified in clinical sequencing.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"}]}
{"text":"The p.A467T variant disrupts the catalytic subunit of POLG.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Her neurological symptoms were attributed to p.A467T.","spans":[{"start":44,"end":51,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Sanger sequencing revealed a mutation at p.A467T.","spans":[{"start":38,"end":45,"label":"GENE_VARIANT"}]}
{"text":"The patient had p.A467T and another recessive variant.","spans":[{"start":14,"end":21,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"R853W is located within the polymerase gamma exon 18.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation R853W was found in affected siblings.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing identified a heterozygous R853W variant.","spans":[{"start":35,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Patient was heterozygous for R853W on the maternal allele.","spans":[{"start":29,"end":34,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The R853W mutation disrupts the active site of POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Sequencing data revealed a likely pathogenic R853W change.","spans":[{"start":41,"end":46,"label":"GENE_VARIANT"}]}
{"text":"He carried the R853W mutation associated with epilepsy.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"The child had homozygous R853W alleles.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"A rare R853W substitution was reported in this cohort.","spans":[{"start":6,"end":11,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic R853W allele was inherited from the mother.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.1288A>T variant causes a missense change in POLG.","spans":[{"start":4,"end":15,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed a c.1288A>T transversion.","spans":[{"start":28,"end":39,"label":"GENE_VARIANT"}]}
{"text":"A homozygous c.1288A>T mutation was identified in this patient.","spans":[{"start":12,"end":23,"label":"GENE_VARIANT"},{"start":51,"end":58,"label":"PATIENT"}]}
{"text":"The nucleotide substitution c.1288A>T alters codon 430.","spans":[{"start":28,"end":39,"label":"GENE_VARIANT"}]}
{"text":"He carried the c.1288A>T mutation in the spacer domain.","spans":[{"start":14,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"c.1288A>T was found in compound heterozygous state.","spans":[{"start":0,"end":11,"label":"GENE_VARIANT"}]}
{"text":"The patient was diagnosed with a c.1288A>T POLG mutation.","spans":[{"start":32,"end":43,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A missense variant c.1288A>T was located in exon 7.","spans":[{"start":19,"end":30,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening identified c.1288A>T in multiple individuals.","spans":[{"start":27,"end":38,"label":"GENE_VARIANT"}]}
{"text":"The mutation c.1288A>T was predicted to be pathogenic.","spans":[{"start":13,"end":24,"label":"GENE_VARIANT"}]}
{"text":"The c.2752T>C substitution was identified through sequencing.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of c.2752T>C.","spans":[{"start":39,"end":49,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried a pathogenic c.2752T>C mutation.","spans":[{"start":31,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense variant c.2752T>C affects exon 18.","spans":[{"start":20,"end":30,"label":"GENE_VARIANT"}]}
{"text":"c.2752T>C was found in a compound heterozygous state.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Clinical testing revealed the c.2752T>C nucleotide change.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"She was identified as a carrier of c.2752T>C.","spans":[{"start":35,"end":45,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.2752T>C variant disrupts polymerase gamma function.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2752T>C was confirmed by sequencing.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"A deleterious mutation, c.2752T>C, was found in POLG.","spans":[{"start":25,"end":35,"label":"GENE_VARIANT"}]}
{"text":"The p.W918R variant was detected in the patient's genome.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis revealed the presence of p.W918R.","spans":[{"start":37,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 was homozygous for the p.W918R mutation.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The pathogenic missense mutation p.W918R affects the polymerase domain.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed p.W918R as the disease-causing variant.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.W918R has been associated with mitochondrial disorders.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"The p.W918R mutation alters a conserved residue in exon 18.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"She carried the p.W918R substitution on one allele.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Functional assays indicated that p.W918R impairs replication.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"}]}
{"text":"The p.W918R variant was confirmed in both alleles.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"The L623W variant was found in compound heterozygous form.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the L623W mutation in POLG.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"L623W is a missense mutation located in the linker domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified L623W as likely pathogenic.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Clinical records showed the presence of L623W.","spans":[{"start":35,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The L623W mutation alters a leucine to tryptophan.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"She harbored the L623W variant in a recessive state.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"L623W was detected during whole-exome sequencing.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic L623W mutation was confirmed in testing.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for L623W was not observed in this case.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The c.752C>T variant affects exon 3 of the POLG gene.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified the c.752C>T nucleotide change.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Patient had a heterozygous c.752C>T mutation.","spans":[{"start":26,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The missense mutation c.752C>T alters codon 251.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"c.752C>T was classified as a likely pathogenic allele.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The patient carried the c.752C>T substitution in exon 3.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"Homozygosity for c.752C>T was not observed.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed a mutation at c.752C>T.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the c.752C>T variant.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.752C>T mutation has been linked to pediatric ataxia.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The p.T251I mutation was discovered in exon 3 of POLG.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"p.T251I is a missense variant affecting a conserved residue.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 was homozygous for p.T251I.","spans":[{"start":26,"end":33,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The presence of p.T251I suggests a pathogenic role.","spans":[{"start":16,"end":23,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis revealed a mutation at p.T251I.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified p.T251I in the patient’s DNA.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The patient carried a heterozygous p.T251I variant.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A pathogenic p.T251I change was noted in exon 3.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.T251I has been linked to mitochondrial dysfunction.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"Her symptoms were consistent with the p.T251I mutation.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.3626_3629dupGATA mutation results in a frameshift.","spans":[{"start":4,"end":23,"label":"GENE_VARIANT"}]}
{"text":"A duplication mutation, c.3626_3629dupGATA, was found in POLG.","spans":[{"start":25,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried the c.3626_3629dupGATA variant on one allele.","spans":[{"start":22,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The frameshift variant c.3626_3629dupGATA is classified as pathogenic.","spans":[{"start":23,"end":42,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed c.3626_3629dupGATA in exon 23.","spans":[{"start":26,"end":45,"label":"GENE_VARIANT"}]}
{"text":"The c.3626_3629dupGATA insertion alters the protein reading frame.","spans":[{"start":4,"end":23,"label":"GENE_VARIANT"}]}
{"text":"This child was found to carry c.3626_3629dupGATA.","spans":[{"start":31,"end":50,"label":"GENE_VARIANT"},{"start":5,"end":10,"label":"PATIENT"}]}
{"text":"Mutation c.3626_3629dupGATA leads to early termination.","spans":[{"start":9,"end":28,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic c.3626_3629dupGATA variant was maternally inherited.","spans":[{"start":14,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.3626_3629dupGATA was confirmed.","spans":[{"start":17,"end":36,"label":"GENE_VARIANT"}]}
{"text":"The c.2993C>T transition was detected in exon 19.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 harbored a heterozygous c.2993C>T mutation.","spans":[{"start":34,"end":44,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The c.2993C>T variant causes a missense change in POLG.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"A c.2993C>T substitution alters a conserved cytosine.","spans":[{"start":2,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified c.2993C>T in a compound heterozygous state.","spans":[{"start":20,"end":30,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.2993C>T has been linked to mitochondrial disease.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2993C>T was not observed.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The c.2993C>T mutation was detected in both alleles.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"She presented with a pathogenic c.2993C>T variant.","spans":[{"start":31,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare c.2993C>T nucleotide change was reported.","spans":[{"start":6,"end":16,"label":"GENE_VARIANT"}]}
{"text":"The p.998S>L variant causes a serine-to-leucine substitution.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.998S>L was detected in exon 21 of POLG.","spans":[{"start":9,"end":18,"label":"GENE_VARIANT"}]}
{"text":"She carried the p.998S>L mutation in heterozygous form.","spans":[{"start":17,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"p.998S>L affects a conserved region of the polymerase domain.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The patient had a pathogenic p.998S>L variant.","spans":[{"start":28,"end":37,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"The missense mutation p.998S>L leads to protein instability.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"}]}
{"text":"A rare variant, p.998S>L, was found during sequencing.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"}]}
{"text":"p.998S>L was confirmed through Sanger sequencing.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Compound heterozygosity involving p.998S>L was observed.","spans":[{"start":31,"end":40,"label":"GENE_VARIANT"}]}
{"text":"She presented with a p.998S>L mutation in the polymerase gene.","spans":[{"start":20,"end":29,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.3550G>C mutation leads to a glycine-to-alanine substitution.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient was found to carry c.3550G>C in exon 22.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed the presence of c.3550G>C.","spans":[{"start":33,"end":43,"label":"GENE_VARIANT"}]}
{"text":"The missense change c.3550G>C affects mitochondrial DNA replication.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.3550G>C was inherited in an autosomal recessive pattern.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"c.3550G>C was identified as a likely pathogenic allele.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The c.3550G>C variant alters codon 1184 in POLG.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Clinical testing confirmed the presence of c.3550G>C.","spans":[{"start":38,"end":48,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic substitution, c.3550G>C, was reported in this case.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"The child had compound heterozygosity involving c.3550G>C.","spans":[{"start":44,"end":54,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"The p.1184D>H mutation changes an acidic residue to basic.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a missense variant p.1184D>H in exon 23.","spans":[{"start":33,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The p.1184D>H substitution was detected via exome sequencing.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed p.1184D>H as a likely pathogenic mutation.","spans":[{"start":20,"end":30,"label":"GENE_VARIANT"}]}
{"text":"p.1184D>H alters a conserved residue in the polymerase domain.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.1184D>H was confirmed by molecular testing.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"She carried the p.1184D>H mutation on the maternal allele.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare p.1184D>H change was reported in multiple patients.","spans":[{"start":6,"end":16,"label":"GENE_VARIANT"}]}
{"text":"The p.1184D>H variant was present in both alleles.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.1184D>H leads to protein destabilization.","spans":[{"start":13,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The p.His945Leu variant alters a conserved amino acid in POLG.","spans":[{"start":4,"end":16,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed the p.His945Leu mutation.","spans":[{"start":27,"end":39,"label":"GENE_VARIANT"}]}
{"text":"The patient was found to carry p.His945Leu on the maternal allele.","spans":[{"start":30,"end":42,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"p.His945Leu was identified as a likely pathogenic substitution.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.His945Leu affects the polymerase domain.","spans":[{"start":21,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.His945Leu was confirmed in this patient.","spans":[{"start":17,"end":29,"label":"GENE_VARIANT"}]}
{"text":"She was heterozygous for the p.His945Leu mutation.","spans":[{"start":29,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The presence of p.His945Leu suggests a functional defect.","spans":[{"start":16,"end":28,"label":"GENE_VARIANT"}]}
{"text":"A rare mutation, p.His945Leu, was discovered in exon 21.","spans":[{"start":16,"end":28,"label":"GENE_VARIANT"}]}
{"text":"p.His945Leu was found in compound heterozygous form.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"}]}
{"text":"The G737R substitution affects the exonuclease domain of POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing identified G737R as a pathogenic variant.","spans":[{"start":25,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The G737R mutation alters a glycine residue critical for function.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the G737R variant on the paternal allele.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed a homozygous G737R mutation.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"}]}
{"text":"G737R was linked to early-onset encephalopathy in this case.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"A rare G737R variant was discovered in the affected child.","spans":[{"start":6,"end":11,"label":"GENE_VARIANT"},{"start":42,"end":47,"label":"PATIENT"}]}
{"text":"The pathogenic G737R allele was inherited maternally.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for G737R was noted in genetic analysis.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"G737R affects a conserved residue near the DNA binding domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The p.M430L mutation lies within the POLG linker domain.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed the p.M430L variant.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Patient 5 carried the p.M430L substitution on both alleles.","spans":[{"start":21,"end":29,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"p.M430L results in a methionine-to-leucine change at codon 430.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"The missense change p.M430L was detected in exon 8.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.M430L was confirmed by sequencing.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"She had a pathogenic p.M430L mutation.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation p.M430L is associated with progressive ataxia.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"A rare p.M430L variant was noted during clinical review.","spans":[{"start":6,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The child was diagnosed with p.M430L-related disease.","spans":[{"start":28,"end":36,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"The 1868T>G variant results in a missense substitution.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed 1868T>G as a pathogenic mutation.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a heterozygous 1868T>G mutation in exon 12.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The nucleotide change 1868T>G alters protein structure.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The 1868T>G substitution has been linked to neurodegeneration.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"A rare mutation, 1868T>G, was found in both alleles.","spans":[{"start":16,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for 1868T>G was reported in this child.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"},{"start":41,"end":46,"label":"PATIENT"}]}
{"text":"She presented with a pathogenic 1868T>G allele.","spans":[{"start":31,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"1868T>G affects the polymerase domain of the protein.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening confirmed the presence of 1868T>G.","spans":[{"start":39,"end":47,"label":"GENE_VARIANT"}]}
{"text":"The 2263A>G mutation results in a nonsynonymous substitution.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"2263A>G alters a nucleotide in exon 14 of the POLG gene.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Patient was found to be compound heterozygous for 2263A>G.","spans":[{"start":44,"end":52,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Mutation 2263A>G was confirmed by Sanger sequencing.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The 2263A>G variant affects a highly conserved position.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"She carried the 2263A>G mutation on the maternal allele.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"2263A>G has been linked to mitochondrial encephalopathy.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for 2263A>G was not observed in this family.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The presence of 2263A>G supports a diagnosis of POLG disorder.","spans":[{"start":16,"end":24,"label":"GENE_VARIANT"}]}
{"text":"A rare nucleotide change, 2263A>G, was detected during screening.","spans":[{"start":26,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The K755E mutation alters a conserved residue in POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"K755E was identified as a pathogenic missense substitution.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Patient 6 carried the K755E variant in a heterozygous state.","spans":[{"start":22,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense variant K755E affects exon 14 of the gene.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed the presence of K755E in both alleles.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic K755E substitution was maternally inherited.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for K755E was reported in the child.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":38,"end":43,"label":"PATIENT"}]}
{"text":"K755E was detected through whole-exome sequencing.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Her neurological phenotype was linked to K755E.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation K755E has been reported in multiple POLG cases.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The c.1760C>T mutation leads to a missense substitution.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a heterozygous c.1760C>T variant.","spans":[{"start":29,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The nucleotide change c.1760C>T was located in exon 10.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic variant, c.1760C>T, was detected during screening.","spans":[{"start":22,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed homozygosity for c.1760C>T.","spans":[{"start":35,"end":45,"label":"GENE_VARIANT"}]}
{"text":"The c.1760C>T substitution disrupted the protein structure.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.1760C>T was found in compound heterozygosity.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"He was found to carry the c.1760C>T mutation.","spans":[{"start":26,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"The variant c.1760C>T has been linked to ataxia.","spans":[{"start":12,"end":22,"label":"GENE_VARIANT"}]}
{"text":"Clinical testing revealed c.1760C>T in both alleles.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"The c.3572A>G change was located in exon 23 of POLG.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the c.3572A>G variant.","spans":[{"start":30,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 was heterozygous for the c.3572A>G mutation.","spans":[{"start":32,"end":42,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Mutation c.3572A>G alters a key residue in the catalytic domain.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.3572A>G substitution was maternally inherited.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Clinical symptoms were consistent with c.3572A>G.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"A rare pathogenic mutation, c.3572A>G, was detected.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.3572A>G was found in the affected child.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":43,"end":48,"label":"PATIENT"}]}
{"text":"He carried the c.3572A>G variant along with a second mutation.","spans":[{"start":14,"end":24,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"Genetic analysis revealed a mutation at c.3572A>G.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"The K1191N mutation affects a conserved lysine residue.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"K1191N was identified through exome sequencing.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Patient 4 carried the K1191N variant in exon 23.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The K1191N substitution was found in both alleles.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"A missense mutation, K1191N, disrupts polymerase function.","spans":[{"start":21,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic role of K1191N has been documented.","spans":[{"start":23,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for K1191N was reported in multiple patients.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"She had K1191N in a compound heterozygous context.","spans":[{"start":8,"end":14,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The K1191N variant lies within the polymerase C-terminal domain.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing showed the K1191N mutation.","spans":[{"start":28,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The c.2542G>A variant was confirmed in clinical testing.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.2542G>A leads to a glycine-to-serine change.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Patient was heterozygous for c.2542G>A in exon 14.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The c.2542G>A substitution affects protein stability.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"A rare mutation, c.2542G>A, was identified through sequencing.","spans":[{"start":16,"end":26,"label":"GENE_VARIANT"}]}
{"text":"She carried c.2542G>A along with a second variant.","spans":[{"start":13,"end":23,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The nucleotide change c.2542G>A was detected in exon 14.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2542G>A was confirmed in the child.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":44,"end":49,"label":"PATIENT"}]}
{"text":"c.2542G>A is a likely pathogenic variant in POLG.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Clinical symptoms matched the c.2542G>A mutation.","spans":[{"start":28,"end":38,"label":"GENE_VARIANT"}]}
{"text":"The c.3643+2TNC variant affects the donor splice site in intron 23.","spans":[{"start":4,"end":16,"label":"GENE_VARIANT"}]}
{"text":"A splice-site mutation, c.3643+2TNC, was confirmed by sequencing.","spans":[{"start":24,"end":36,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried a heterozygous c.3643+2TNC mutation.","spans":[{"start":31,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The c.3643+2TNC mutation disrupts normal mRNA splicing.","spans":[{"start":4,"end":16,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.3643+2TNC was detected in this case.","spans":[{"start":17,"end":29,"label":"GENE_VARIANT"}]}
{"text":"c.3643+2TNC was found in a child with epilepsy.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"},{"start":26,"end":31,"label":"PATIENT"}]}
{"text":"The splice donor site variant c.3643+2TNC affects exon recognition.","spans":[{"start":28,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed the c.3643+2TNC variant.","spans":[{"start":29,"end":41,"label":"GENE_VARIANT"}]}
{"text":"A rare pathogenic splice-site mutation, c.3643+2TNC, was detected.","spans":[{"start":37,"end":49,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the c.3643+2TNC splice mutation.","spans":[{"start":27,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The R953C mutation replaces a conserved arginine residue.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 carried a heterozygous R953C variant.","spans":[{"start":31,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"R953C was identified as a missense mutation in POLG.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The R953C variant lies within the polymerase domain.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of R953C.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"}]}
{"text":"R953C has been associated with mitochondrial depletion syndrome.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic R953C mutation was detected in this family.","spans":[{"start":12,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The child was homozygous for R953C at diagnosis.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She presented with seizures linked to the R953C variant.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The R953C substitution altered enzyme activity.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The p.W748S mutation is one of the most common POLG variants.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed compound heterozygosity with p.W748S.","spans":[{"start":48,"end":56,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 was found to carry the p.W748S variant.","spans":[{"start":32,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense change p.W748S is associated with Alpers syndrome.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing identified p.W748S in exon 15.","spans":[{"start":27,"end":35,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.W748S was reported in multiple cases.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"p.W748S disrupts the catalytic domain of polymerase gamma.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"The child carried the pathogenic p.W748S allele.","spans":[{"start":31,"end":39,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"Her clinical symptoms were attributed to p.W748S.","spans":[{"start":38,"end":46,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.W748S variant has been documented in POLG-related epilepsy.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"The p.A862T mutation alters an alanine residue at codon 862.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"p.A862T was confirmed as a pathogenic missense variant.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Patient 5 was heterozygous for p.A862T at diagnosis.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense mutation p.A862T was identified in exon 18.","spans":[{"start":21,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.A862T was found in the affected child.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"},{"start":43,"end":48,"label":"PATIENT"}]}
{"text":"She was found to carry p.A862T in the maternal allele.","spans":[{"start":25,"end":33,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.A862T variant affects the polymerase C-terminal domain.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"p.A862T is associated with progressive external ophthalmoplegia.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"The clinical picture was consistent with p.A862T.","spans":[{"start":36,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.A862T was detected during routine genetic screening.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The p.H277L mutation occurs at the exonuclease domain of POLG.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Patient 6 carried the pathogenic p.H277L variant.","spans":[{"start":32,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense substitution p.H277L was confirmed via sequencing.","spans":[{"start":25,"end":33,"label":"GENE_VARIANT"}]}
{"text":"p.H277L changes histidine to leucine at codon 277.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.H277L was not observed in this family.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the p.H277L mutation in exon 5.","spans":[{"start":27,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.H277L variant affects replication fidelity.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed p.H277L in compound heterozygosity.","spans":[{"start":27,"end":35,"label":"GENE_VARIANT"}]}
{"text":"p.H277L has been associated with neurodevelopmental symptoms.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.H277L impacts exonuclease proofreading activity.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The P765T mutation alters a conserved residue in POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried the P765T variant in exon 15.","spans":[{"start":22,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sequencing identified P765T as a likely pathogenic mutation.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The missense change P765T has been observed in epileptic phenotypes.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for P765T was confirmed in this case.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic P765T variant was inherited maternally.","spans":[{"start":12,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The P765T substitution affects polymerase function.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"She was heterozygous for the P765T allele.","spans":[{"start":29,"end":34,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare missense mutation, P765T, was found in POLG.","spans":[{"start":25,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The child carried P765T in compound heterozygous form.","spans":[{"start":18,"end":23,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"The p.Arg1096Cys variant affects a conserved arginine residue.","spans":[{"start":4,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the p.Arg1096Cys substitution on one allele.","spans":[{"start":21,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Sanger sequencing confirmed the p.Arg1096Cys mutation.","spans":[{"start":27,"end":41,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.Arg1096Cys was not observed.","spans":[{"start":17,"end":31,"label":"GENE_VARIANT"}]}
{"text":"p.Arg1096Cys is classified as a likely pathogenic change.","spans":[{"start":0,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.Arg1096Cys lies in exon 23.","spans":[{"start":21,"end":35,"label":"GENE_VARIANT"}]}
{"text":"She presented with symptoms linked to p.Arg1096Cys.","spans":[{"start":38,"end":52,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The child had p.Arg1096Cys in compound heterozygosity.","spans":[{"start":14,"end":28,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"A rare variant, p.Arg1096Cys, was found during testing.","spans":[{"start":14,"end":28,"label":"GENE_VARIANT"}]}
{"text":"p.Arg1096Cys alters protein structure and enzyme activity.","spans":[{"start":0,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The R807C mutation was confirmed by genetic sequencing.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"R807C lies within the polymerase gamma linker domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 was heterozygous for the R807C variant.","spans":[{"start":32,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"A rare missense variant, R807C, was found in exon 17.","spans":[{"start":24,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for R807C was reported in affected siblings.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The R807C substitution results in structural alteration.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"R807C has been linked to progressive external ophthalmoplegia.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"She carried the R807C mutation on the maternal allele.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation R807C was detected during diagnostic screening.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"R807C disrupts catalytic efficiency of polymerase gamma.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The G2491C mutation alters a highly conserved glycine.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"G2491C was identified through whole-exome sequencing.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Patient 4 carried a heterozygous G2491C substitution.","spans":[{"start":34,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sanger sequencing confirmed the G2491C variant.","spans":[{"start":30,"end":36,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for G2491C was not observed in this case.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"G2491C has been associated with early-onset ataxia.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Mutation G2491C disrupts polymerase proofreading activity.","spans":[{"start":9,"end":15,"label":"GENE_VARIANT"}]}
{"text":"The patient had G2491C in compound heterozygosity.","spans":[{"start":18,"end":24,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A pathogenic variant, G2491C, was reported in this child.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"},{"start":50,"end":55,"label":"PATIENT"}]}
{"text":"She was found to carry the G2491C mutation in exon 23.","spans":[{"start":27,"end":33,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.K1191R mutation changes lysine to arginine at codon 1191.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of p.K1191R.","spans":[{"start":39,"end":48,"label":"GENE_VARIANT"}]}
{"text":"Patient 6 was compound heterozygous for p.K1191R.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The p.K1191R variant affects the polymerase C-terminal domain.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.K1191R was not observed in this cohort.","spans":[{"start":17,"end":26,"label":"GENE_VARIANT"}]}
{"text":"A rare pathogenic variant, p.K1191R, was identified.","spans":[{"start":26,"end":35,"label":"GENE_VARIANT"}]}
{"text":"The missense substitution p.K1191R is linked to seizures.","spans":[{"start":25,"end":34,"label":"GENE_VARIANT"}]}
{"text":"She carried p.K1191R in exon 23 of the POLG gene.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation p.K1191R alters the structure of polymerase gamma.","spans":[{"start":9,"end":18,"label":"GENE_VARIANT"}]}
{"text":"p.K1191R was inherited from the maternal allele.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The c.2542G>A variant was detected in the proband.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Genetic sequencing revealed a pathogenic c.2542G>A mutation.","spans":[{"start":39,"end":49,"label":"GENE_VARIANT"}]}
{"text":"Patient carried c.2542G>A on the maternal allele.","spans":[{"start":16,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The missense mutation c.2542G>A affected DNA replication.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"c.2542G>A is located within the exonuclease domain.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"She was found to harbor the c.2542G>A variant.","spans":[{"start":28,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare variant, c.2542G>A, was identified in exon 18.","spans":[{"start":15,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2542G>A was not observed.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of c.2542G>A.","spans":[{"start":39,"end":49,"label":"GENE_VARIANT"}]}
{"text":"The mutation c.2542G>A disrupts enzyme fidelity.","spans":[{"start":13,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The c.1399G>A variant was classified as pathogenic.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed c.1399G>A in compound heterozygosity.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 carried the c.1399G>A mutation.","spans":[{"start":22,"end":32,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"c.1399G>A occurs at a conserved site in the exon region.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic variant c.1399G>A was maternally inherited.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"A missense change c.1399G>A affects the polymerase domain.","spans":[{"start":19,"end":29,"label":"GENE_VARIANT"}]}
{"text":"She was heterozygous for the c.1399G>A allele.","spans":[{"start":30,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"c.1399G>A is frequently associated with early-onset seizures.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.1399G>A alters protein conformation.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.1399G>A mutation affects the fidelity of replication.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The C752T mutation was identified during sequencing.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 carried a heterozygous C752T variant.","spans":[{"start":33,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Homozygosity for C752T was confirmed in this case.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The missense substitution C752T disrupts exon 6 function.","spans":[{"start":26,"end":31,"label":"GENE_VARIANT"}]}
{"text":"Sequencing revealed the pathogenic C752T allele.","spans":[{"start":33,"end":38,"label":"GENE_VARIANT"}]}
{"text":"C752T was located within the DNA binding domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Mutation C752T was detected in the proband.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The child carried the C752T mutation.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She was heterozygous for C752T on the maternal allele.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"C752T was found in patients with mitochondrial disease.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The C1760T mutation results in a missense substitution.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Patient 4 carried C1760T on one allele.","spans":[{"start":18,"end":24,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"C1760T was confirmed through Sanger sequencing.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"A rare variant, C1760T, was found in exon 19.","spans":[{"start":15,"end":21,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for C1760T was identified in the affected sibling.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The missense substitution C1760T affects protein folding.","spans":[{"start":26,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Mutation C1760T disrupts normal enzyme activity.","spans":[{"start":9,"end":15,"label":"GENE_VARIANT"}]}
{"text":"The child carried the C1760T variant in POLG.","spans":[{"start":21,"end":27,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She presented with a C1760T variant in compound heterozygosity.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"C1760T is linked to early-onset mitochondrial encephalopathy.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"The p.Ala467Thr mutation substitutes alanine with threonine.","spans":[{"start":4,"end":17,"label":"GENE_VARIANT"}]}
{"text":"p.Ala467Thr is one of the most common POLG mutations.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Patient 5 was homozygous for p.Ala467Thr.","spans":[{"start":27,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sanger sequencing confirmed the p.Ala467Thr variant.","spans":[{"start":29,"end":42,"label":"GENE_VARIANT"}]}
{"text":"A compound heterozygous state including p.Ala467Thr was detected.","spans":[{"start":34,"end":47,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.Ala467Thr has been linked to Alpers syndrome.","spans":[{"start":9,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The child carried p.Ala467Thr with severe symptoms.","spans":[{"start":18,"end":31,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She was found to have the p.Ala467Thr substitution.","spans":[{"start":26,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for p.Ala467Thr was confirmed in exon 7.","spans":[{"start":17,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The p.Ala467Thr variant alters the linker domain structure.","spans":[{"start":4,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The E1143G variant was identified in the sequencing panel.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"E1143G was associated with late-onset progressive ataxia.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried the heterozygous E1143G mutation.","spans":[{"start":30,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The substitution E1143G alters a conserved glutamic acid.","spans":[{"start":18,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of E1143G.","spans":[{"start":39,"end":45,"label":"GENE_VARIANT"}]}
{"text":"She was found to harbor E1143G on the paternal allele.","spans":[{"start":24,"end":30,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for E1143G was not observed in this family.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The E1143G mutation was located in the polymerase domain.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"In exon 21, the E1143G variant has been frequently reported.","spans":[{"start":14,"end":20,"label":"GENE_VARIANT"}]}
{"text":"E1143G causes disruption in mitochondrial DNA synthesis.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"The p.Trp748Ser substitution has been reported in POLG1.","spans":[{"start":4,"end":17,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a homozygous p.Trp748Ser variant.","spans":[{"start":25,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The missense mutation p.Trp748Ser lies in the linker region.","spans":[{"start":21,"end":34,"label":"GENE_VARIANT"}]}
{"text":"p.Trp748Ser was detected by targeted gene sequencing.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"She was found to harbor the p.Trp748Ser allele.","spans":[{"start":27,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for p.Trp748Ser has been linked to Alpers syndrome.","spans":[{"start":17,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The variant p.Trp748Ser disrupts polymerase gamma function.","spans":[{"start":12,"end":25,"label":"GENE_VARIANT"}]}
{"text":"p.Trp748Ser was reported in multiple unrelated cases.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"This child presented with the p.Trp748Ser mutation.","spans":[{"start":28,"end":41,"label":"GENE_VARIANT"},{"start":5,"end":10,"label":"PATIENT"}]}
{"text":"A pathogenic p.Trp748Ser variant was inherited maternally.","spans":[{"start":12,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The c.2243G>C mutation affects the exonuclease domain.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 had a heterozygous c.2243G>C substitution.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of c.2243G>C.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"A rare missense variant, c.2243G>C, was identified in exon 12.","spans":[{"start":24,"end":34,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2243G>C was not detected.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The c.2243G>C variant disrupts enzyme proofreading activity.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"She carried the c.2243G>C mutation on the maternal allele.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation c.2243G>C was confirmed by molecular testing.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.2243G>C substitution alters replication fidelity.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"c.2243G>C is a potentially pathogenic POLG variant.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The p.D1186H variant lies in a conserved catalytic region.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a compound heterozygous p.D1186H mutation.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Mutation p.D1186H has been implicated in mitochondrial disease.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the p.D1186H substitution.","spans":[{"start":29,"end":39,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.D1186H alters polymerase activity.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"p.D1186H was detected in exon 23 of the POLG gene.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the p.D1186H allele.","spans":[{"start":26,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The child had p.D1186H in compound heterozygosity.","spans":[{"start":14,"end":24,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"A pathogenic change, p.D1186H, was observed.","spans":[{"start":22,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.D1186H has not been reported.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The p.K512M mutation alters a lysine residue at codon 512.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 carried the heterozygous p.K512M variant.","spans":[{"start":34,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sanger sequencing revealed the presence of p.K512M.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"}]}
{"text":"p.K512M is a missense change located in exon 9.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.K512M disrupts the polymerase active site.","spans":[{"start":9,"end":18,"label":"GENE_VARIANT"}]}
{"text":"She carried p.K512M on the paternal allele.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.K512M substitution impairs enzymatic function.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"A rare variant, p.K512M, was found in affected individuals.","spans":[{"start":15,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.K512M was not observed.","spans":[{"start":17,"end":26,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.K512M was maternally inherited.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"}]}
"text":"Genetic analysis confirmed the presence of A467T.","spans":[{"start":40,"end":45,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the pathogenic A467T mutation.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"At diagnosis, the A467T mutation was already known.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"A467T was found to be associated with early-onset symptoms.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing revealed A467T as a likely pathogenic allele.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The presence of A467T explains the patient's phenotype.","spans":[{"start":16,"end":21,"label":"GENE_VARIANT"},{"start":35,"end":42,"label":"PATIENT"}]}
{"text":"Genetic testing showed that she harbored A467T.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"},{"start":32,"end":35,"label":"PATIENT"}]}
{"text":"The A467T mutation was first described in this family.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for A467T was confirmed by clinical sequencing.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The W748S variant has been linked to mitochondrial disease.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried a heterozygous W748S mutation.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"W748S was confirmed by Sanger sequencing.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified W748S as the causative variant.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"}]}
{"text":"The presence of W748S supports the clinical suspicion.","spans":[{"start":16,"end":21,"label":"GENE_VARIANT"}]}
{"text":"W748S was inherited from the maternal allele.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The W748S mutation correlated with a severe phenotype.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the W748S variant.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A pathogenic W748S mutation was detected in testing.","spans":[{"start":13,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing revealed a homozygous W748S mutation.","spans":[{"start":35,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The T251I mutation was first documented in 2004.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"A heterozygous T251I variant was identified in this case.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"T251I was present in both alleles of the patient.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"},{"start":36,"end":43,"label":"PATIENT"}]}
{"text":"She carried the rare T251I mutation in POLG1.","spans":[{"start":24,"end":29,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the T251I variant in exon 2.","spans":[{"start":23,"end":28,"label":"GENE_VARIANT"}]}
{"text":"T251I has been linked to ataxia and epilepsy.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic T251I allele was inherited maternally.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for T251I was confirmed through testing.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"T251I was detected in the proband's mitochondrial genome.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The patient was diagnosed with a T251I mutation.","spans":[{"start":32,"end":37,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"P587L was discovered in a screen of mitochondrial genes.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The patient carried a heterozygous P587L mutation.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"She harbored a pathogenic variant: P587L.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The P587L mutation was inherited in an autosomal recessive pattern.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis identified the P587L variant in exon 3.","spans":[{"start":28,"end":33,"label":"GENE_VARIANT"}]}
{"text":"P587L was linked to neurodegenerative symptoms.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing results showed the presence of P587L.","spans":[{"start":38,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Her symptoms were associated with P587L mutation.","spans":[{"start":33,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A homozygous P587L variant was detected in the child.","spans":[{"start":13,"end":18,"label":"GENE_VARIANT"},{"start":41,"end":46,"label":"PATIENT"}]}
{"text":"The pathogenic role of P587L was supported by evidence.","spans":[{"start":23,"end":28,"label":"GENE_VARIANT"}]}
{"text":"G848S was identified as a pathogenic mutation in POLG.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The patient was heterozygous for G848S.","spans":[{"start":31,"end":36,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"She carried the G848S mutation on one allele.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Genetic sequencing confirmed the G848S substitution.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"}]}
{"text":"The G848S variant was linked to neurodegeneration.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Clinical analysis revealed a homozygous G848S mutation.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"}]}
{"text":"Mutation G848S was identified in the patient sample.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"At diagnosis, G848S was found in the child’s DNA.","spans":[{"start":13,"end":18,"label":"GENE_VARIANT"},{"start":35,"end":40,"label":"PATIENT"}]}
{"text":"The boy was diagnosed with a G848S variant.","spans":[{"start":30,"end":35,"label":"GENE_VARIANT"},{"start":4,"end":7,"label":"PATIENT"}]}
{"text":"Presence of G848S mutation explained her clinical symptoms.","spans":[{"start":12,"end":17,"label":"GENE_VARIANT"},{"start":41,"end":44,"label":"PATIENT"}]}
{"text":"The p.P587L substitution was identified in the POLG gene.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Genetic sequencing confirmed a pathogenic p.P587L variant.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 was homozygous for the p.P587L mutation.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense mutation p.P587L altered the polymerase domain.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"}]}
{"text":"p.P587L is a well-documented mutation associated with ataxia.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed the presence of p.P587L.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.P587L was found in exon 3 of POLG.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"She was identified as a carrier of the p.P587L variant.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The pathogenic variant p.P587L was inherited maternally.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"p.P587L has been implicated in early-onset mitochondrial disorders.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"The p.G848S variant affects a conserved residue in POLG.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified p.G848S as a likely pathogenic mutation.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The p.G848S substitution was located within the polymerase domain.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 was compound heterozygous, carrying p.G848S.","spans":[{"start":43,"end":50,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Mutation p.G848S was reported in previous POLG studies.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"A highly conserved site is disrupted by p.G848S.","spans":[{"start":37,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Her clinical presentation was consistent with p.G848S.","spans":[{"start":43,"end":50,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for p.G848S was detected during testing.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"}]}
{"text":"p.G848S was classified as a deleterious mutation.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"The boy was found to carry the pathogenic p.G848S variant.","spans":[{"start":41,"end":48,"label":"GENE_VARIANT"},{"start":4,"end":7,"label":"PATIENT"}]}
{"text":"The p.A467T mutation is a common variant in POLG-related disorders.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis confirmed compound heterozygosity for p.A467T.","spans":[{"start":48,"end":55,"label":"GENE_VARIANT"}]}
{"text":"p.A467T affects a residue critical for polymerase activity.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 carried the p.A467T mutation along with another variant.","spans":[{"start":21,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"A missense mutation at p.A467T was found to be pathogenic.","spans":[{"start":22,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.A467T was identified in clinical sequencing.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"}]}
{"text":"The p.A467T variant disrupts the catalytic subunit of POLG.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Her neurological symptoms were attributed to p.A467T.","spans":[{"start":44,"end":51,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Sanger sequencing revealed a mutation at p.A467T.","spans":[{"start":38,"end":45,"label":"GENE_VARIANT"}]}
{"text":"The patient had p.A467T and another recessive variant.","spans":[{"start":14,"end":21,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"R853W is located within the polymerase gamma exon 18.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation R853W was found in affected siblings.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing identified a heterozygous R853W variant.","spans":[{"start":35,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Patient was heterozygous for R853W on the maternal allele.","spans":[{"start":29,"end":34,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The R853W mutation disrupts the active site of POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Sequencing data revealed a likely pathogenic R853W change.","spans":[{"start":41,"end":46,"label":"GENE_VARIANT"}]}
{"text":"He carried the R853W mutation associated with epilepsy.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"The child had homozygous R853W alleles.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"A rare R853W substitution was reported in this cohort.","spans":[{"start":6,"end":11,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic R853W allele was inherited from the mother.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.1288A>T variant causes a missense change in POLG.","spans":[{"start":4,"end":15,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed a c.1288A>T transversion.","spans":[{"start":28,"end":39,"label":"GENE_VARIANT"}]}
{"text":"A homozygous c.1288A>T mutation was identified in this patient.","spans":[{"start":12,"end":23,"label":"GENE_VARIANT"},{"start":51,"end":58,"label":"PATIENT"}]}
{"text":"The nucleotide substitution c.1288A>T alters codon 430.","spans":[{"start":28,"end":39,"label":"GENE_VARIANT"}]}
{"text":"He carried the c.1288A>T mutation in the spacer domain.","spans":[{"start":14,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"c.1288A>T was found in compound heterozygous state.","spans":[{"start":0,"end":11,"label":"GENE_VARIANT"}]}
{"text":"The patient was diagnosed with a c.1288A>T POLG mutation.","spans":[{"start":32,"end":43,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A missense variant c.1288A>T was located in exon 7.","spans":[{"start":19,"end":30,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening identified c.1288A>T in multiple individuals.","spans":[{"start":27,"end":38,"label":"GENE_VARIANT"}]}
{"text":"The mutation c.1288A>T was predicted to be pathogenic.","spans":[{"start":13,"end":24,"label":"GENE_VARIANT"}]}
{"text":"The c.2752T>C substitution was identified through sequencing.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of c.2752T>C.","spans":[{"start":39,"end":49,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried a pathogenic c.2752T>C mutation.","spans":[{"start":31,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense variant c.2752T>C affects exon 18.","spans":[{"start":20,"end":30,"label":"GENE_VARIANT"}]}
{"text":"c.2752T>C was found in a compound heterozygous state.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Clinical testing revealed the c.2752T>C nucleotide change.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"She was identified as a carrier of c.2752T>C.","spans":[{"start":35,"end":45,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.2752T>C variant disrupts polymerase gamma function.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2752T>C was confirmed by sequencing.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"A deleterious mutation, c.2752T>C, was found in POLG.","spans":[{"start":25,"end":35,"label":"GENE_VARIANT"}]}
{"text":"The p.W918R variant was detected in the patient's genome.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis revealed the presence of p.W918R.","spans":[{"start":37,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 was homozygous for the p.W918R mutation.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The pathogenic missense mutation p.W918R affects the polymerase domain.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed p.W918R as the disease-causing variant.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.W918R has been associated with mitochondrial disorders.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"The p.W918R mutation alters a conserved residue in exon 18.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"She carried the p.W918R substitution on one allele.","spans":[{"start":17,"end":24,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Functional assays indicated that p.W918R impairs replication.","spans":[{"start":30,"end":37,"label":"GENE_VARIANT"}]}
{"text":"The p.W918R variant was confirmed in both alleles.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"The L623W variant was found in compound heterozygous form.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the L623W mutation in POLG.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"L623W is a missense mutation located in the linker domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified L623W as likely pathogenic.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Clinical records showed the presence of L623W.","spans":[{"start":35,"end":40,"label":"GENE_VARIANT"}]}
{"text":"The L623W mutation alters a leucine to tryptophan.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"She harbored the L623W variant in a recessive state.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"L623W was detected during whole-exome sequencing.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic L623W mutation was confirmed in testing.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for L623W was not observed in this case.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The c.752C>T variant affects exon 3 of the POLG gene.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified the c.752C>T nucleotide change.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Patient had a heterozygous c.752C>T mutation.","spans":[{"start":26,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The missense mutation c.752C>T alters codon 251.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"c.752C>T was classified as a likely pathogenic allele.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The patient carried the c.752C>T substitution in exon 3.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"Homozygosity for c.752C>T was not observed.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed a mutation at c.752C>T.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the c.752C>T variant.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.752C>T mutation has been linked to pediatric ataxia.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The p.T251I mutation was discovered in exon 3 of POLG.","spans":[{"start":4,"end":11,"label":"GENE_VARIANT"}]}
{"text":"p.T251I is a missense variant affecting a conserved residue.","spans":[{"start":0,"end":7,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 was homozygous for p.T251I.","spans":[{"start":26,"end":33,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The presence of p.T251I suggests a pathogenic role.","spans":[{"start":16,"end":23,"label":"GENE_VARIANT"}]}
{"text":"Genetic analysis revealed a mutation at p.T251I.","spans":[{"start":36,"end":43,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified p.T251I in the patient’s DNA.","spans":[{"start":20,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The patient carried a heterozygous p.T251I variant.","spans":[{"start":33,"end":40,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A pathogenic p.T251I change was noted in exon 3.","spans":[{"start":12,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.T251I has been linked to mitochondrial dysfunction.","spans":[{"start":9,"end":16,"label":"GENE_VARIANT"}]}
{"text":"Her symptoms were consistent with the p.T251I mutation.","spans":[{"start":35,"end":42,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.3626_3629dupGATA mutation results in a frameshift.","spans":[{"start":4,"end":23,"label":"GENE_VARIANT"}]}
{"text":"A duplication mutation, c.3626_3629dupGATA, was found in POLG.","spans":[{"start":25,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried the c.3626_3629dupGATA variant on one allele.","spans":[{"start":22,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The frameshift variant c.3626_3629dupGATA is classified as pathogenic.","spans":[{"start":23,"end":42,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed c.3626_3629dupGATA in exon 23.","spans":[{"start":26,"end":45,"label":"GENE_VARIANT"}]}
{"text":"The c.3626_3629dupGATA insertion alters the protein reading frame.","spans":[{"start":4,"end":23,"label":"GENE_VARIANT"}]}
{"text":"This child was found to carry c.3626_3629dupGATA.","spans":[{"start":31,"end":50,"label":"GENE_VARIANT"},{"start":5,"end":10,"label":"PATIENT"}]}
{"text":"Mutation c.3626_3629dupGATA leads to early termination.","spans":[{"start":9,"end":28,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic c.3626_3629dupGATA variant was maternally inherited.","spans":[{"start":14,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.3626_3629dupGATA was confirmed.","spans":[{"start":17,"end":36,"label":"GENE_VARIANT"}]}
{"text":"The c.2993C>T transition was detected in exon 19.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 harbored a heterozygous c.2993C>T mutation.","spans":[{"start":34,"end":44,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The c.2993C>T variant causes a missense change in POLG.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"A c.2993C>T substitution alters a conserved cytosine.","spans":[{"start":2,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Sequencing identified c.2993C>T in a compound heterozygous state.","spans":[{"start":20,"end":30,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.2993C>T has been linked to mitochondrial disease.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2993C>T was not observed.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The c.2993C>T mutation was detected in both alleles.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"She presented with a pathogenic c.2993C>T variant.","spans":[{"start":31,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare c.2993C>T nucleotide change was reported.","spans":[{"start":6,"end":16,"label":"GENE_VARIANT"}]}
{"text":"The p.998S>L variant causes a serine-to-leucine substitution.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.998S>L was detected in exon 21 of POLG.","spans":[{"start":9,"end":18,"label":"GENE_VARIANT"}]}
{"text":"She carried the p.998S>L mutation in heterozygous form.","spans":[{"start":17,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"p.998S>L affects a conserved region of the polymerase domain.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The patient had a pathogenic p.998S>L variant.","spans":[{"start":28,"end":37,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"The missense mutation p.998S>L leads to protein instability.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"}]}
{"text":"A rare variant, p.998S>L, was found during sequencing.","spans":[{"start":16,"end":25,"label":"GENE_VARIANT"}]}
{"text":"p.998S>L was confirmed through Sanger sequencing.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Compound heterozygosity involving p.998S>L was observed.","spans":[{"start":31,"end":40,"label":"GENE_VARIANT"}]}
{"text":"She presented with a p.998S>L mutation in the polymerase gene.","spans":[{"start":20,"end":29,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The c.3550G>C mutation leads to a glycine-to-alanine substitution.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient was found to carry c.3550G>C in exon 22.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed the presence of c.3550G>C.","spans":[{"start":33,"end":43,"label":"GENE_VARIANT"}]}
{"text":"The missense change c.3550G>C affects mitochondrial DNA replication.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.3550G>C was inherited in an autosomal recessive pattern.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"c.3550G>C was identified as a likely pathogenic allele.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The c.3550G>C variant alters codon 1184 in POLG.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Clinical testing confirmed the presence of c.3550G>C.","spans":[{"start":38,"end":48,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic substitution, c.3550G>C, was reported in this case.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"The child had compound heterozygosity involving c.3550G>C.","spans":[{"start":44,"end":54,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"The p.1184D>H mutation changes an acidic residue to basic.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a missense variant p.1184D>H in exon 23.","spans":[{"start":33,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The p.1184D>H substitution was detected via exome sequencing.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed p.1184D>H as a likely pathogenic mutation.","spans":[{"start":20,"end":30,"label":"GENE_VARIANT"}]}
{"text":"p.1184D>H alters a conserved residue in the polymerase domain.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.1184D>H was confirmed by molecular testing.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"She carried the p.1184D>H mutation on the maternal allele.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare p.1184D>H change was reported in multiple patients.","spans":[{"start":6,"end":16,"label":"GENE_VARIANT"}]}
{"text":"The p.1184D>H variant was present in both alleles.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The mutation p.1184D>H leads to protein destabilization.","spans":[{"start":13,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The p.His945Leu variant alters a conserved amino acid in POLG.","spans":[{"start":4,"end":16,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed the p.His945Leu mutation.","spans":[{"start":27,"end":39,"label":"GENE_VARIANT"}]}
{"text":"The patient was found to carry p.His945Leu on the maternal allele.","spans":[{"start":30,"end":42,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"p.His945Leu was identified as a likely pathogenic substitution.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.His945Leu affects the polymerase domain.","spans":[{"start":21,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.His945Leu was confirmed in this patient.","spans":[{"start":17,"end":29,"label":"GENE_VARIANT"}]}
{"text":"She was heterozygous for the p.His945Leu mutation.","spans":[{"start":29,"end":41,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The presence of p.His945Leu suggests a functional defect.","spans":[{"start":16,"end":28,"label":"GENE_VARIANT"}]}
{"text":"A rare mutation, p.His945Leu, was discovered in exon 21.","spans":[{"start":16,"end":28,"label":"GENE_VARIANT"}]}
{"text":"p.His945Leu was found in compound heterozygous form.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"}]}
{"text":"The G737R substitution affects the exonuclease domain of POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing identified G737R as a pathogenic variant.","spans":[{"start":25,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The G737R mutation alters a glycine residue critical for function.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the G737R variant on the paternal allele.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Sequencing revealed a homozygous G737R mutation.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"}]}
{"text":"G737R was linked to early-onset encephalopathy in this case.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"A rare G737R variant was discovered in the affected child.","spans":[{"start":6,"end":11,"label":"GENE_VARIANT"},{"start":42,"end":47,"label":"PATIENT"}]}
{"text":"The pathogenic G737R allele was inherited maternally.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for G737R was noted in genetic analysis.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"G737R affects a conserved residue near the DNA binding domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The p.M430L mutation lies within the POLG linker domain.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed the p.M430L variant.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Patient 5 carried the p.M430L substitution on both alleles.","spans":[{"start":21,"end":29,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"p.M430L results in a methionine-to-leucine change at codon 430.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"The missense change p.M430L was detected in exon 8.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.M430L was confirmed by sequencing.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"She had a pathogenic p.M430L mutation.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation p.M430L is associated with progressive ataxia.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"A rare p.M430L variant was noted during clinical review.","spans":[{"start":6,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The child was diagnosed with p.M430L-related disease.","spans":[{"start":28,"end":36,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"The 1868T>G variant results in a missense substitution.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed 1868T>G as a pathogenic mutation.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a heterozygous 1868T>G mutation in exon 12.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The nucleotide change 1868T>G alters protein structure.","spans":[{"start":22,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The 1868T>G substitution has been linked to neurodegeneration.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"A rare mutation, 1868T>G, was found in both alleles.","spans":[{"start":16,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for 1868T>G was reported in this child.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"},{"start":41,"end":46,"label":"PATIENT"}]}
{"text":"She presented with a pathogenic 1868T>G allele.","spans":[{"start":31,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"1868T>G affects the polymerase domain of the protein.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Genetic screening confirmed the presence of 1868T>G.","spans":[{"start":39,"end":47,"label":"GENE_VARIANT"}]}
{"text":"The 2263A>G mutation results in a nonsynonymous substitution.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"2263A>G alters a nucleotide in exon 14 of the POLG gene.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Patient was found to be compound heterozygous for 2263A>G.","spans":[{"start":44,"end":52,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Mutation 2263A>G was confirmed by Sanger sequencing.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The 2263A>G variant affects a highly conserved position.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"She carried the 2263A>G mutation on the maternal allele.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"2263A>G has been linked to mitochondrial encephalopathy.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for 2263A>G was not observed in this family.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The presence of 2263A>G supports a diagnosis of POLG disorder.","spans":[{"start":16,"end":24,"label":"GENE_VARIANT"}]}
{"text":"A rare nucleotide change, 2263A>G, was detected during screening.","spans":[{"start":26,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The K755E mutation alters a conserved residue in POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"K755E was identified as a pathogenic missense substitution.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Patient 6 carried the K755E variant in a heterozygous state.","spans":[{"start":22,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense variant K755E affects exon 14 of the gene.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Sequencing confirmed the presence of K755E in both alleles.","spans":[{"start":34,"end":39,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic K755E substitution was maternally inherited.","spans":[{"start":14,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for K755E was reported in the child.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":38,"end":43,"label":"PATIENT"}]}
{"text":"K755E was detected through whole-exome sequencing.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Her neurological phenotype was linked to K755E.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation K755E has been reported in multiple POLG cases.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The c.1760C>T mutation leads to a missense substitution.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a heterozygous c.1760C>T variant.","spans":[{"start":29,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The nucleotide change c.1760C>T was located in exon 10.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic variant, c.1760C>T, was detected during screening.","spans":[{"start":22,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed homozygosity for c.1760C>T.","spans":[{"start":35,"end":45,"label":"GENE_VARIANT"}]}
{"text":"The c.1760C>T substitution disrupted the protein structure.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.1760C>T was found in compound heterozygosity.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"He was found to carry the c.1760C>T mutation.","spans":[{"start":26,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"The variant c.1760C>T has been linked to ataxia.","spans":[{"start":12,"end":22,"label":"GENE_VARIANT"}]}
{"text":"Clinical testing revealed c.1760C>T in both alleles.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"The c.3572A>G change was located in exon 23 of POLG.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the c.3572A>G variant.","spans":[{"start":30,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 was heterozygous for the c.3572A>G mutation.","spans":[{"start":32,"end":42,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Mutation c.3572A>G alters a key residue in the catalytic domain.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.3572A>G substitution was maternally inherited.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Clinical symptoms were consistent with c.3572A>G.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"A rare pathogenic mutation, c.3572A>G, was detected.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.3572A>G was found in the affected child.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":43,"end":48,"label":"PATIENT"}]}
{"text":"He carried the c.3572A>G variant along with a second mutation.","spans":[{"start":14,"end":24,"label":"GENE_VARIANT"},{"start":0,"end":2,"label":"PATIENT"}]}
{"text":"Genetic analysis revealed a mutation at c.3572A>G.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"The K1191N mutation affects a conserved lysine residue.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"K1191N was identified through exome sequencing.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Patient 4 carried the K1191N variant in exon 23.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The K1191N substitution was found in both alleles.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"A missense mutation, K1191N, disrupts polymerase function.","spans":[{"start":21,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic role of K1191N has been documented.","spans":[{"start":23,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for K1191N was reported in multiple patients.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"She had K1191N in a compound heterozygous context.","spans":[{"start":8,"end":14,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The K1191N variant lies within the polymerase C-terminal domain.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing showed the K1191N mutation.","spans":[{"start":28,"end":34,"label":"GENE_VARIANT"}]}
{"text":"The c.2542G>A variant was confirmed in clinical testing.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.2542G>A leads to a glycine-to-serine change.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Patient was heterozygous for c.2542G>A in exon 14.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The c.2542G>A substitution affects protein stability.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"A rare mutation, c.2542G>A, was identified through sequencing.","spans":[{"start":16,"end":26,"label":"GENE_VARIANT"}]}
{"text":"She carried c.2542G>A along with a second variant.","spans":[{"start":13,"end":23,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The nucleotide change c.2542G>A was detected in exon 14.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2542G>A was confirmed in the child.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":44,"end":49,"label":"PATIENT"}]}
{"text":"c.2542G>A is a likely pathogenic variant in POLG.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Clinical symptoms matched the c.2542G>A mutation.","spans":[{"start":28,"end":38,"label":"GENE_VARIANT"}]}
{"text":"The c.3643+2TNC variant affects the donor splice site in intron 23.","spans":[{"start":4,"end":16,"label":"GENE_VARIANT"}]}
{"text":"A splice-site mutation, c.3643+2TNC, was confirmed by sequencing.","spans":[{"start":24,"end":36,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried a heterozygous c.3643+2TNC mutation.","spans":[{"start":31,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The c.3643+2TNC mutation disrupts normal mRNA splicing.","spans":[{"start":4,"end":16,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.3643+2TNC was detected in this case.","spans":[{"start":17,"end":29,"label":"GENE_VARIANT"}]}
{"text":"c.3643+2TNC was found in a child with epilepsy.","spans":[{"start":0,"end":12,"label":"GENE_VARIANT"},{"start":26,"end":31,"label":"PATIENT"}]}
{"text":"The splice donor site variant c.3643+2TNC affects exon recognition.","spans":[{"start":28,"end":40,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed the c.3643+2TNC variant.","spans":[{"start":29,"end":41,"label":"GENE_VARIANT"}]}
{"text":"A rare pathogenic splice-site mutation, c.3643+2TNC, was detected.","spans":[{"start":37,"end":49,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the c.3643+2TNC splice mutation.","spans":[{"start":27,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The R953C mutation replaces a conserved arginine residue.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 carried a heterozygous R953C variant.","spans":[{"start":31,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"R953C was identified as a missense mutation in POLG.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The R953C variant lies within the polymerase domain.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of R953C.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"}]}
{"text":"R953C has been associated with mitochondrial depletion syndrome.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic R953C mutation was detected in this family.","spans":[{"start":12,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The child was homozygous for R953C at diagnosis.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She presented with seizures linked to the R953C variant.","spans":[{"start":39,"end":44,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The R953C substitution altered enzyme activity.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The p.W748S mutation is one of the most common POLG variants.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Genetic testing confirmed compound heterozygosity with p.W748S.","spans":[{"start":48,"end":56,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 was found to carry the p.W748S variant.","spans":[{"start":32,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense change p.W748S is associated with Alpers syndrome.","spans":[{"start":20,"end":28,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing identified p.W748S in exon 15.","spans":[{"start":27,"end":35,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.W748S was reported in multiple cases.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"p.W748S disrupts the catalytic domain of polymerase gamma.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"The child carried the pathogenic p.W748S allele.","spans":[{"start":31,"end":39,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"Her clinical symptoms were attributed to p.W748S.","spans":[{"start":38,"end":46,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.W748S variant has been documented in POLG-related epilepsy.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"The p.A862T mutation alters an alanine residue at codon 862.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"p.A862T was confirmed as a pathogenic missense variant.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Patient 5 was heterozygous for p.A862T at diagnosis.","spans":[{"start":29,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense mutation p.A862T was identified in exon 18.","spans":[{"start":21,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.A862T was found in the affected child.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"},{"start":43,"end":48,"label":"PATIENT"}]}
{"text":"She was found to carry p.A862T in the maternal allele.","spans":[{"start":25,"end":33,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.A862T variant affects the polymerase C-terminal domain.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"p.A862T is associated with progressive external ophthalmoplegia.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"The clinical picture was consistent with p.A862T.","spans":[{"start":36,"end":44,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.A862T was detected during routine genetic screening.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The p.H277L mutation occurs at the exonuclease domain of POLG.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Patient 6 carried the pathogenic p.H277L variant.","spans":[{"start":32,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The missense substitution p.H277L was confirmed via sequencing.","spans":[{"start":25,"end":33,"label":"GENE_VARIANT"}]}
{"text":"p.H277L changes histidine to leucine at codon 277.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.H277L was not observed in this family.","spans":[{"start":17,"end":25,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the p.H277L mutation in exon 5.","spans":[{"start":27,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.H277L variant affects replication fidelity.","spans":[{"start":4,"end":12,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed p.H277L in compound heterozygosity.","spans":[{"start":27,"end":35,"label":"GENE_VARIANT"}]}
{"text":"p.H277L has been associated with neurodevelopmental symptoms.","spans":[{"start":0,"end":8,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.H277L impacts exonuclease proofreading activity.","spans":[{"start":9,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The P765T mutation alters a conserved residue in POLG.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried the P765T variant in exon 15.","spans":[{"start":22,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sequencing identified P765T as a likely pathogenic mutation.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The missense change P765T has been observed in epileptic phenotypes.","spans":[{"start":20,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for P765T was confirmed in this case.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"A pathogenic P765T variant was inherited maternally.","spans":[{"start":12,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The P765T substitution affects polymerase function.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"She was heterozygous for the P765T allele.","spans":[{"start":29,"end":34,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare missense mutation, P765T, was found in POLG.","spans":[{"start":25,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The child carried P765T in compound heterozygous form.","spans":[{"start":18,"end":23,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"The p.Arg1096Cys variant affects a conserved arginine residue.","spans":[{"start":4,"end":18,"label":"GENE_VARIANT"}]}
{"text":"Patient carried the p.Arg1096Cys substitution on one allele.","spans":[{"start":21,"end":35,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Sanger sequencing confirmed the p.Arg1096Cys mutation.","spans":[{"start":27,"end":41,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.Arg1096Cys was not observed.","spans":[{"start":17,"end":31,"label":"GENE_VARIANT"}]}
{"text":"p.Arg1096Cys is classified as a likely pathogenic change.","spans":[{"start":0,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.Arg1096Cys lies in exon 23.","spans":[{"start":21,"end":35,"label":"GENE_VARIANT"}]}
{"text":"She presented with symptoms linked to p.Arg1096Cys.","spans":[{"start":38,"end":52,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The child had p.Arg1096Cys in compound heterozygosity.","spans":[{"start":14,"end":28,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"A rare variant, p.Arg1096Cys, was found during testing.","spans":[{"start":14,"end":28,"label":"GENE_VARIANT"}]}
{"text":"p.Arg1096Cys alters protein structure and enzyme activity.","spans":[{"start":0,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The R807C mutation was confirmed by genetic sequencing.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"R807C lies within the polymerase gamma linker domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 was heterozygous for the R807C variant.","spans":[{"start":32,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"A rare missense variant, R807C, was found in exon 17.","spans":[{"start":24,"end":29,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for R807C was reported in affected siblings.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The R807C substitution results in structural alteration.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"R807C has been linked to progressive external ophthalmoplegia.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"She carried the R807C mutation on the maternal allele.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation R807C was detected during diagnostic screening.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"R807C disrupts catalytic efficiency of polymerase gamma.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The G2491C mutation alters a highly conserved glycine.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"G2491C was identified through whole-exome sequencing.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Patient 4 carried a heterozygous G2491C substitution.","spans":[{"start":34,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sanger sequencing confirmed the G2491C variant.","spans":[{"start":30,"end":36,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for G2491C was not observed in this case.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"G2491C has been associated with early-onset ataxia.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Mutation G2491C disrupts polymerase proofreading activity.","spans":[{"start":9,"end":15,"label":"GENE_VARIANT"}]}
{"text":"The patient had G2491C in compound heterozygosity.","spans":[{"start":18,"end":24,"label":"GENE_VARIANT"},{"start":4,"end":11,"label":"PATIENT"}]}
{"text":"A pathogenic variant, G2491C, was reported in this child.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"},{"start":50,"end":55,"label":"PATIENT"}]}
{"text":"She was found to carry the G2491C mutation in exon 23.","spans":[{"start":27,"end":33,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.K1191R mutation changes lysine to arginine at codon 1191.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of p.K1191R.","spans":[{"start":39,"end":48,"label":"GENE_VARIANT"}]}
{"text":"Patient 6 was compound heterozygous for p.K1191R.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The p.K1191R variant affects the polymerase C-terminal domain.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.K1191R was not observed in this cohort.","spans":[{"start":17,"end":26,"label":"GENE_VARIANT"}]}
{"text":"A rare pathogenic variant, p.K1191R, was identified.","spans":[{"start":26,"end":35,"label":"GENE_VARIANT"}]}
{"text":"The missense substitution p.K1191R is linked to seizures.","spans":[{"start":25,"end":34,"label":"GENE_VARIANT"}]}
{"text":"She carried p.K1191R in exon 23 of the POLG gene.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation p.K1191R alters the structure of polymerase gamma.","spans":[{"start":9,"end":18,"label":"GENE_VARIANT"}]}
{"text":"p.K1191R was inherited from the maternal allele.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"The c.2542G>A variant was detected in the proband.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Genetic sequencing revealed a pathogenic c.2542G>A mutation.","spans":[{"start":39,"end":49,"label":"GENE_VARIANT"}]}
{"text":"Patient carried c.2542G>A on the maternal allele.","spans":[{"start":16,"end":26,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The missense mutation c.2542G>A affected DNA replication.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"c.2542G>A is located within the exonuclease domain.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"She was found to harbor the c.2542G>A variant.","spans":[{"start":28,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"A rare variant, c.2542G>A, was identified in exon 18.","spans":[{"start":15,"end":25,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2542G>A was not observed.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of c.2542G>A.","spans":[{"start":39,"end":49,"label":"GENE_VARIANT"}]}
{"text":"The mutation c.2542G>A disrupts enzyme fidelity.","spans":[{"start":13,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The c.1399G>A variant was classified as pathogenic.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing revealed c.1399G>A in compound heterozygosity.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 carried the c.1399G>A mutation.","spans":[{"start":22,"end":32,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"c.1399G>A occurs at a conserved site in the exon region.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The pathogenic variant c.1399G>A was maternally inherited.","spans":[{"start":23,"end":33,"label":"GENE_VARIANT"}]}
{"text":"A missense change c.1399G>A affects the polymerase domain.","spans":[{"start":19,"end":29,"label":"GENE_VARIANT"}]}
{"text":"She was heterozygous for the c.1399G>A allele.","spans":[{"start":30,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"c.1399G>A is frequently associated with early-onset seizures.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Mutation c.1399G>A alters protein conformation.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.1399G>A mutation affects the fidelity of replication.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The C752T mutation was identified during sequencing.","spans":[{"start":4,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 carried a heterozygous C752T variant.","spans":[{"start":33,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Homozygosity for C752T was confirmed in this case.","spans":[{"start":17,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The missense substitution C752T disrupts exon 6 function.","spans":[{"start":26,"end":31,"label":"GENE_VARIANT"}]}
{"text":"Sequencing revealed the pathogenic C752T allele.","spans":[{"start":33,"end":38,"label":"GENE_VARIANT"}]}
{"text":"C752T was located within the DNA binding domain.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"Mutation C752T was detected in the proband.","spans":[{"start":9,"end":14,"label":"GENE_VARIANT"}]}
{"text":"The child carried the C752T mutation.","spans":[{"start":21,"end":26,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She was heterozygous for C752T on the maternal allele.","spans":[{"start":27,"end":32,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"C752T was found in patients with mitochondrial disease.","spans":[{"start":0,"end":5,"label":"GENE_VARIANT"}]}
{"text":"The C1760T mutation results in a missense substitution.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"Patient 4 carried C1760T on one allele.","spans":[{"start":18,"end":24,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"C1760T was confirmed through Sanger sequencing.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"A rare variant, C1760T, was found in exon 19.","spans":[{"start":15,"end":21,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for C1760T was identified in the affected sibling.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The missense substitution C1760T affects protein folding.","spans":[{"start":26,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Mutation C1760T disrupts normal enzyme activity.","spans":[{"start":9,"end":15,"label":"GENE_VARIANT"}]}
{"text":"The child carried the C1760T variant in POLG.","spans":[{"start":21,"end":27,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She presented with a C1760T variant in compound heterozygosity.","spans":[{"start":22,"end":28,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"C1760T is linked to early-onset mitochondrial encephalopathy.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"The p.Ala467Thr mutation substitutes alanine with threonine.","spans":[{"start":4,"end":17,"label":"GENE_VARIANT"}]}
{"text":"p.Ala467Thr is one of the most common POLG mutations.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Patient 5 was homozygous for p.Ala467Thr.","spans":[{"start":27,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sanger sequencing confirmed the p.Ala467Thr variant.","spans":[{"start":29,"end":42,"label":"GENE_VARIANT"}]}
{"text":"A compound heterozygous state including p.Ala467Thr was detected.","spans":[{"start":34,"end":47,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.Ala467Thr has been linked to Alpers syndrome.","spans":[{"start":9,"end":22,"label":"GENE_VARIANT"}]}
{"text":"The child carried p.Ala467Thr with severe symptoms.","spans":[{"start":18,"end":31,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"She was found to have the p.Ala467Thr substitution.","spans":[{"start":26,"end":39,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for p.Ala467Thr was confirmed in exon 7.","spans":[{"start":17,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The p.Ala467Thr variant alters the linker domain structure.","spans":[{"start":4,"end":17,"label":"GENE_VARIANT"}]}
{"text":"The E1143G variant was identified in the sequencing panel.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"E1143G was associated with late-onset progressive ataxia.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"Patient 1 carried the heterozygous E1143G mutation.","spans":[{"start":30,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"The substitution E1143G alters a conserved glutamic acid.","spans":[{"start":18,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the presence of E1143G.","spans":[{"start":39,"end":45,"label":"GENE_VARIANT"}]}
{"text":"She was found to harbor E1143G on the paternal allele.","spans":[{"start":24,"end":30,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for E1143G was not observed in this family.","spans":[{"start":17,"end":23,"label":"GENE_VARIANT"}]}
{"text":"The E1143G mutation was located in the polymerase domain.","spans":[{"start":4,"end":10,"label":"GENE_VARIANT"}]}
{"text":"In exon 21, the E1143G variant has been frequently reported.","spans":[{"start":14,"end":20,"label":"GENE_VARIANT"}]}
{"text":"E1143G causes disruption in mitochondrial DNA synthesis.","spans":[{"start":0,"end":6,"label":"GENE_VARIANT"}]}
{"text":"The p.Trp748Ser substitution has been reported in POLG1.","spans":[{"start":4,"end":17,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a homozygous p.Trp748Ser variant.","spans":[{"start":25,"end":38,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"The missense mutation p.Trp748Ser lies in the linker region.","spans":[{"start":21,"end":34,"label":"GENE_VARIANT"}]}
{"text":"p.Trp748Ser was detected by targeted gene sequencing.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"She was found to harbor the p.Trp748Ser allele.","spans":[{"start":27,"end":40,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Homozygosity for p.Trp748Ser has been linked to Alpers syndrome.","spans":[{"start":17,"end":30,"label":"GENE_VARIANT"}]}
{"text":"The variant p.Trp748Ser disrupts polymerase gamma function.","spans":[{"start":12,"end":25,"label":"GENE_VARIANT"}]}
{"text":"p.Trp748Ser was reported in multiple unrelated cases.","spans":[{"start":0,"end":13,"label":"GENE_VARIANT"}]}
{"text":"This child presented with the p.Trp748Ser mutation.","spans":[{"start":28,"end":41,"label":"GENE_VARIANT"},{"start":5,"end":10,"label":"PATIENT"}]}
{"text":"A pathogenic p.Trp748Ser variant was inherited maternally.","spans":[{"start":12,"end":25,"label":"GENE_VARIANT"}]}
{"text":"The c.2243G>C mutation affects the exonuclease domain.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient 2 had a heterozygous c.2243G>C substitution.","spans":[{"start":27,"end":37,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sequencing confirmed the presence of c.2243G>C.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"}]}
{"text":"A rare missense variant, c.2243G>C, was identified in exon 12.","spans":[{"start":24,"end":34,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for c.2243G>C was not detected.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The c.2243G>C variant disrupts enzyme proofreading activity.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"She carried the c.2243G>C mutation on the maternal allele.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"Mutation c.2243G>C was confirmed by molecular testing.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"The c.2243G>C substitution alters replication fidelity.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"c.2243G>C is a potentially pathogenic POLG variant.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"The p.D1186H variant lies in a conserved catalytic region.","spans":[{"start":4,"end":14,"label":"GENE_VARIANT"}]}
{"text":"Patient carried a compound heterozygous p.D1186H mutation.","spans":[{"start":36,"end":46,"label":"GENE_VARIANT"},{"start":0,"end":7,"label":"PATIENT"}]}
{"text":"Mutation p.D1186H has been implicated in mitochondrial disease.","spans":[{"start":9,"end":19,"label":"GENE_VARIANT"}]}
{"text":"Sanger sequencing confirmed the p.D1186H substitution.","spans":[{"start":29,"end":39,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.D1186H alters polymerase activity.","spans":[{"start":21,"end":31,"label":"GENE_VARIANT"}]}
{"text":"p.D1186H was detected in exon 23 of the POLG gene.","spans":[{"start":0,"end":10,"label":"GENE_VARIANT"}]}
{"text":"She was found to carry the p.D1186H allele.","spans":[{"start":26,"end":36,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The child had p.D1186H in compound heterozygosity.","spans":[{"start":14,"end":24,"label":"GENE_VARIANT"},{"start":4,"end":9,"label":"PATIENT"}]}
{"text":"A pathogenic change, p.D1186H, was observed.","spans":[{"start":22,"end":32,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.D1186H has not been reported.","spans":[{"start":17,"end":27,"label":"GENE_VARIANT"}]}
{"text":"The p.K512M mutation alters a lysine residue at codon 512.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"Patient 3 carried the heterozygous p.K512M variant.","spans":[{"start":34,"end":43,"label":"GENE_VARIANT"},{"start":0,"end":9,"label":"PATIENT"}]}
{"text":"Sanger sequencing revealed the presence of p.K512M.","spans":[{"start":37,"end":46,"label":"GENE_VARIANT"}]}
{"text":"p.K512M is a missense change located in exon 9.","spans":[{"start":0,"end":9,"label":"GENE_VARIANT"}]}
{"text":"Mutation p.K512M disrupts the polymerase active site.","spans":[{"start":9,"end":18,"label":"GENE_VARIANT"}]}
{"text":"She carried p.K512M on the paternal allele.","spans":[{"start":13,"end":22,"label":"GENE_VARIANT"},{"start":0,"end":3,"label":"PATIENT"}]}
{"text":"The p.K512M substitution impairs enzymatic function.","spans":[{"start":4,"end":13,"label":"GENE_VARIANT"}]}
{"text":"A rare variant, p.K512M, was found in affected individuals.","spans":[{"start":15,"end":24,"label":"GENE_VARIANT"}]}
{"text":"Homozygosity for p.K512M was not observed.","spans":[{"start":17,"end":26,"label":"GENE_VARIANT"}]}
{"text":"The missense mutation p.K512M was maternally inherited.","spans":[{"start":21,"end":30,"label":"GENE_VARIANT"}]}